###begin article-title 0
###xml 61 79 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Translation of intronless RNAs is strongly stimulated by the Epstein-Barr virus mRNA export factor EB2
###end article-title 0
###begin p 1
Present address: Cahora Medina-Palazon, Westmead Institute for Cancer Research, University of Sydney, Westmead Millenium Institute, Westmead, New South Wales 2145, Australia.
###end p 1
###begin p 2
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
###end p 2
###begin p 3
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus protein (EB2) allows the nuclear export of a particular subset of early and late viral RNAs derived from intronless genes. EB2 is conserved among most herpesvirus members and its presence is essential for the production of infectious particles. Here we show that, besides its role as a nuclear export factor, EB2 strongly stimulates translation of unspliced mRNAs without affecting overall cellular translation. Interestingly, this effect can be reversed by the addition of an intron within the gene. The spliced mRNA is then efficiently exported and translated even in the absence of EB2. Moreover, we show that EB2 associates with translating ribosomes and increases the proportion of its target RNA in the polyribosomal fraction. Finally, testing of EB2 homolog proteins derived from EBV-related herpesviruses, shows that, even if they play similar roles within the replication cycle of their respective virus, their mechanisms of action are different.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
In eukaryotic cells, gene expression is tightly controlled from the biogenesis of messenger RNAs (mRNAs) within the cell nucleus, until their export and translation in the cytoplasm (1). In particular, the control of mRNA translation is a multi-step complex mechanism mediated by a large number of factors. Translation initiation appears to be the rate-limiting and most regulated step of the overall translation mechanism (2,3). Regulation of translation initiation is mediated mostly by initiation factors, which recruit the 40S ribosomal subunit to the 5' cap of the mRNA, allow scanning to the initiation codon and then the recruitment of the 60S ribosomal subunit (4).
###end p 5
###begin p 6
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5 B6 B7 B8 B9 B10 B11 B12">5&#8211;12</xref>
###xml 587 588 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
Even though maturation of pre-mRNAs occurs in a different cellular compartment than translation, proteins that participate in the former process can also play a role in the latter. Indeed, translation stimulation of intron-containing genes has been observed in several systems and is linked to proteins that participate either in splicing or in the export of spliced mRNAs (5-12). Among these, the exon junction complex (EJC), which is deposited during splicing and plays an important role in mRNA surveillance, is able to modulate translation of spliced mRNAs through the mTOR pathway (7). Other proteins involved in translation stimulation of spliced mRNAs comprise the Ser-Arg-rich (SR) proteins that play a role not only in pre-mRNA splicing and spliceosome assembly but also in splice-site recognition and selection (13,14). Conversely, recent data have also shown that some of the SR proteins, which shuttle from the nucleus to the cytoplasm together with the spliced mRNA, can be associated with translating ribosomes to stimulate the translation of spliced mRNAs (11,15). This would allow the cell to ensure that only fully spliced RNAs are expressed as opposed to unspliced or incompletely spliced RNAs that could result in translation of aberrant proteins.
###end p 6
###begin p 7
###xml 372 377 372 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15 B16 B17 B18">15&#8211;18</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 627 630 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 747 752 747 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19 B20 B21 B22">19&#8211;22</xref>
###xml 222 226 <span type="species:ncbi:11855?1.0">MPMV</span>
Viruses have evolved different mechanisms to efficiently export and translate unspliced RNAs. One example is the constitutive transport element (CTE) present in simple retroviruses, such as the Mason-Pfizner monkey virus (MPMV), which interacts with the TAP/NXF1 export protein and the cellular protein NXT1/p15 to promote export and translation of unspliced genomic RNA (15-18). Again, translation stimulation of unspliced RNAs containing the CTE seems to rely on SR proteins such as 9G8 (15). For complex retroviruses, such as lentiviruses, the unspliced genomic RNA is exported by the viral protein Rev which interacts with cis-acting sequences located within the envelope coding region of the RNA, allowing export and translation stimulation (19-22).
###end p 7
###begin p 8
###xml 167 175 167 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 180 187 180 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 189 194 189 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23 B24 B25">23&#8211;25</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 415 420 415 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26 B27 B28">26&#8211;28</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 723 728 723 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29 B30 B31">29&#8211;31</xref>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 974 979 974 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1016 1018 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 24 27 <span type="species:ncbi:10376">EBV</span>
###xml 565 568 <span type="species:ncbi:10376">EBV</span>
###xml 607 610 <span type="species:ncbi:10376">EBV</span>
###xml 687 714 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
###xml 716 720 <span type="species:ncbi:10298?0.9473684210526315">HSV1</span>
###xml 758 761 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 846 865 <span type="species:ncbi:10381">herpesvirus saimiri</span>
The Epstein-Barr virus (EBV) early protein EB2 (also known as BMFL1, Mta or SM) shares several features with mRNA export factors. It is able to interact with RNA both in vitro and in vivo (23-25), it shuttles between the nucleus and the cytoplasm and it allows the cytoplasmic accumulation of unspliced RNAs generated from intronless and intron-containing genes, probably by the recruitment of REF and TAP/NXF1 (24,26-28). EB2 is essential for the production of viral particles and promotes the nuclear export of some early and most late viral mRNAs generated from EBV intronless genes (28). Moreover, like EBV many other herpesviruses code for a protein similar to EB2, i.e. ICP27 from herpes simplex virus type 1 (HSV1) (29-31), UL69 from cytomegalovirus (CMV) (32) ORF57 from Kaposi's sarcoma-associated herpesvirus (KSHV) (33) and ORF57 from herpesvirus saimiri (HVS) (34). All these proteins act as nuclear mRNA export factors but surprisingly their function cannot be trans-complemented between each other (27,35).
###end p 8
###begin p 9
###xml 1164 1167 <span type="species:ncbi:10376">EBV</span>
###xml 1185 1190 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1192 1195 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
As cellular mRNA export factors, EB2 shuttles from the nucleus to the cytoplasm, probably associated with its target mRNAs, suggesting that it could also affect their translation. We thus tested the effect of EB2 on translation from an intronless reporter construct coding for the Renilla luciferase. In this system, translation stimulation was measured by analyzing the expression levels of Renilla luciferase normalized to the amount of cytoplasmic mRNAs determined by quantitative PCR. Our results show that EB2 strongly and specifically stimulates translation of intronless mRNAs without affecting overall cellular translation or protein stability. Introduction of an intron in this construct stimulates the efficiency of export and translation of the luciferase mRNA and at the same time abrogates the effect of EB2. Interestingly, the increase in translation of the luciferase mRNA generated from the intronless construct in the presence of EB2, correlates with an increase in the proportion of luciferase mRNA associated with polyribosomes. Moreover, we show that EB2 itself is associated with polyribosomes. Finally, a comparison between EB2 homologs from EBV-related viruses (HSV-1, CMV, KSHV) led us to conclude that their mechanisms of action are different.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Cell lines and transfections
###end title 11
###begin p 12
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1255 1256 1234 1235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 126 130 <span type="species:ncbi:9913">calf</span>
###xml 272 275 <span type="species:ncbi:10376">EBV</span>
HeLa and HEK293T cells were grown in Dulbecco's modified Eagle medium supplemented with penicillin, streptomycin and 5% fetal calf serum (Invitrogen). NIH3T3 PKR-deficient cells (36) and NIH3T3 wild-type cells were grown as described for HeLa cells. For experiments using EBV gene-derived constructs, transfections were performed in 100 mm plates using calcium phosphate with 15 microg of total DNA (0.5 microg of pTRE2-Flag.BDLF1, 0.25 microg of pCI-Flag.EB2 and 0.5 microg of pTet-On or pTet-Off expression vectors (Clontech) and pUC18 up to 15 microg). When necessary, doxycyclin was added at a concentration of 1 mug/ml. For experiments using the luciferase reporter plasmids, transfections were carried out in 60 mm plates using Lipofectamine 2000 (Invitrogen) following the manufacturer's protocol. For the metabolic labeling experiments, transfection of HeLa cells with the EB2 expression plasmid was carried out in six-well plates using Lipofectamine 2000 (Invitrogen). The efficiency of transfection was evaluated by transfecting the pEGFP-C1 plasmid (Clontech) in the same conditions and counting the number of green fluorescent cells by FACS. Over 60% of the cells expressed GFP. For polysomal fractionation, HEK293T cells were seeded at 2 x 106 on a 150 mm culture dish 3 days before polysomal fractionation. Forty-eight hours before harvesting, cells were transfected with 1.25 microg of luciferase-coding plasmid together or not with 6.25 microg of pCI-Flag.EB2, using PEI reagent.
###end p 12
###begin title 13
Plasmids
###end title 13
###begin p 14
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 573 575 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1055 1057 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1140 1142 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 89 92 <span type="species:ncbi:10376">EBV</span>
###xml 410 415 <span type="species:ncbi:9606">human</span>
###xml 722 727 <span type="species:ncbi:9606">human</span>
The pCI-Flag.EB2 construct has been previously described (28). For pTRE2-Flag.BDLF1, the EBV BDLF1 open reading frame tagged with the Flag epitope was amplified by PCR and cloned into the BamHI and XbaI sites of the pTRE2 expression plasmid (Clontech). The pTet-On vector was supplied by Clontech (Tet-Off and Tet-On gene expression systems). The pcDNAGlobinRen reporter plasmid was constructed by cloning the human beta-globin 5'UTR (with the authentic initiation codon) followed by the Renilla luciferase reporter gene, amplified by PCR from the p-Globin Renilla vector (37) into the double digested (XbaI/AflII) pcDNA3.1 expression vector. For the pcDNAIntron-GlobinRen, the sequence corresponding to the intron of the human beta-globin gene was amplified by PCR and cloned into the pcDNAGlobinRen vector previously digested by XbaI. pCI-mycORF57 contained the complete ORF57 coding sequence (first exon included) cloned in frame with the myc epitope, in pCI (Promega). The expression plasmid for UL69 (pCMV-UL69) was kindly provided by T. Stamminger (38). The expression plasmid for ICP27 (pCI-FlagICP27) has been previously described (27).
###end p 14
###begin title 15
RNA extraction and real-time quantitative PCR (RT-PCR) from cytoplasmic RNAs
###end title 15
###begin p 16
###xml 139 140 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 276 277 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 614 616 600 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
Cells were first scraped from the dish and then resuspended in 200 microl of cold RLNa buffer (10 mM Tris-HCl (pH 8), 10 mM NaCl, 3 mM MgCl2, 1 mM DTT, 0.5% NP40 and 10 U/ml of RNaseOUT (Invitrogen). After 5 min incubation on ice, lysed cells were centrifuged for 2 min at 400g at 4degreesC and the supernatant was then recovered. One milliliter of Trizol (Invitrogen) was then added to the supernatant and RNAs were extracted following the Trizol protocol provided by the manufacturer. Cytoplasmic RNAs (1 microg) were treated with RQ1 DNAse (Promega) to avoid DNA contamination and reversed transcribed with (dT)16 and 1 microl of Superscript II enzyme (Invitrogen) in a 20 microl reaction mix at 42degreesC for 1 h.
###end p 16
###begin p 17
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 118 125 118 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 434 441 421 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 673 680 657 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 683 691 667 675 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 721 722 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 721 722 705 706 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>a</sup></bold>
###xml 721 722 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><bold><sup>a</sup></bold></xref>
###xml 691 722 675 706 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="18">PCR primers used in this study<xref ref-type="table-fn" rid="TF1"><bold><sup>a</sup></bold></xref></p>
###xml 691 722 675 706 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="18">PCR primers used in this study<xref ref-type="table-fn" rid="TF1"><bold><sup>a</sup></bold></xref></p></caption>
###xml 722 733 706 717 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Primer name</th>
###xml 733 748 717 732 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Primer sequence</th>
###xml 722 748 706 732 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Primer name</th><th rowspan="1" colspan="1">Primer sequence</th></tr>
###xml 722 748 706 732 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Primer name</th><th rowspan="1" colspan="1">Primer sequence</th></tr></thead>
###xml 748 761 732 745 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">BDLF1 forward</td>
###xml 761 783 745 767 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CAGATTTGAAAGTGGTAGTGTC</td>
###xml 748 783 732 767 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">BDLF1 forward</td><td rowspan="1" colspan="1">CAGATTTGAAAGTGGTAGTGTC</td></tr>
###xml 783 796 767 780 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">BDLF1 reverse</td>
###xml 796 819 780 803 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TTATCTTAACCAGCAAGTGGCCG</td>
###xml 783 819 767 803 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">BDLF1 reverse</td><td rowspan="1" colspan="1">TTATCTTAACCAGCAAGTGGCCG</td></tr>
###xml 819 845 803 826 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#946;-actin forward (Human)</td>
###xml 845 867 826 848 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GCTGCGTGTGGCTCCCGAGGAG</td>
###xml 819 867 803 848 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#946;-actin forward (Human)</td><td rowspan="1" colspan="1">GCTGCGTGTGGCTCCCGAGGAG</td></tr>
###xml 867 893 848 871 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#946;-actin reverse (Human)</td>
###xml 893 916 871 894 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ATCTTCATTGTGCTGGGTGCCAG</td>
###xml 867 916 848 894 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#946;-actin reverse (Human)</td><td rowspan="1" colspan="1">ATCTTCATTGTGCTGGGTGCCAG</td></tr>
###xml 916 937 894 915 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GAPDH forward (Human)</td>
###xml 937 958 915 936 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TCCACCACCCTGTTGCTGTAG</td>
###xml 916 958 894 936 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">GAPDH forward (Human)</td><td rowspan="1" colspan="1">TCCACCACCCTGTTGCTGTAG</td></tr>
###xml 958 979 936 957 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GAPDH reverse (Human)</td>
###xml 979 1000 957 978 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ACCCACTCCTCCACCTTTGAC</td>
###xml 958 1000 936 978 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">GAPDH reverse (Human)</td><td rowspan="1" colspan="1">ACCCACTCCTCCACCTTTGAC</td></tr>
###xml 1000 1020 978 998 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HPRT forward (Mouse)</td>
###xml 1020 1041 998 1019 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TCATTATGCCGAGGATTTGGA</td>
###xml 1000 1041 978 1019 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HPRT forward (Mouse)</td><td rowspan="1" colspan="1">TCATTATGCCGAGGATTTGGA</td></tr>
###xml 1041 1061 1019 1039 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HPRT reverse (Mouse)</td>
###xml 1061 1081 1039 1059 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CAGAGGGCCACAATGTGATG</td>
###xml 1041 1081 1019 1059 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HPRT reverse (Mouse)</td><td rowspan="1" colspan="1">CAGAGGGCCACAATGTGATG</td></tr>
###xml 1081 1096 1059 1074 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Renilla forward</td>
###xml 1096 1123 1074 1101 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AGGTGAAGTTCGTCGTCCAACATTATC</td>
###xml 1081 1123 1059 1101 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Renilla forward</td><td rowspan="1" colspan="1">AGGTGAAGTTCGTCGTCCAACATTATC</td></tr>
###xml 1123 1138 1101 1116 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Renilla reverse</td>
###xml 1138 1166 1116 1144 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GAAACTTCTTGGCACCTTCAACAATAGC</td>
###xml 1123 1166 1101 1144 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Renilla reverse</td><td rowspan="1" colspan="1">GAAACTTCTTGGCACCTTCAACAATAGC</td></tr>
###xml 1166 1190 1144 1168 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">18S rRNA forward (Human)</td>
###xml 1190 1210 1168 1188 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GTGGAGCGATTTGTCTGGTT</td>
###xml 1166 1210 1144 1188 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">18S rRNA forward (Human)</td><td rowspan="1" colspan="1">GTGGAGCGATTTGTCTGGTT</td></tr>
###xml 1210 1234 1188 1212 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">18S rRNA reverse (Human)</td>
###xml 1234 1254 1212 1232 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CGCTGAGCCAGTCAGTGTAG</td>
###xml 1210 1254 1188 1232 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">18S rRNA reverse (Human)</td><td rowspan="1" colspan="1">CGCTGAGCCAGTCAGTGTAG</td></tr>
###xml 1254 1278 1232 1256 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">28S rRNA forward (Human)</td>
###xml 1278 1298 1256 1276 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TGGGTTTTAAGCAGGAGGTG</td>
###xml 1254 1298 1232 1276 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">28S rRNA forward (Human)</td><td rowspan="1" colspan="1">TGGGTTTTAAGCAGGAGGTG</td></tr>
###xml 1298 1322 1276 1300 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">28S rRNA reverse (Human)</td>
###xml 1322 1342 1300 1320 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AACCTGTCTCACGACGGTCT</td>
###xml 1298 1342 1276 1320 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">28S rRNA reverse (Human)</td><td rowspan="1" colspan="1">AACCTGTCTCACGACGGTCT</td></tr>
###xml 1342 1360 1320 1338 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">U6 forward (Human)</td>
###xml 1360 1380 1338 1358 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CGCTTCGGCAGCACATATAC</td>
###xml 1342 1380 1320 1358 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">U6 forward (Human)</td><td rowspan="1" colspan="1">CGCTTCGGCAGCACATATAC</td></tr>
###xml 1380 1398 1358 1376 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">U6 reverse (Human)</td>
###xml 1398 1419 1376 1397 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">AAAATATGGAACGCTTCACGA</td>
###xml 1380 1419 1358 1397 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">U6 reverse (Human)</td><td rowspan="1" colspan="1">AAAATATGGAACGCTTCACGA</td></tr>
###xml 748 1419 732 1397 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">BDLF1 forward</td><td rowspan="1" colspan="1">CAGATTTGAAAGTGGTAGTGTC</td></tr><tr><td rowspan="1" colspan="1">BDLF1 reverse</td><td rowspan="1" colspan="1">TTATCTTAACCAGCAAGTGGCCG</td></tr><tr><td rowspan="1" colspan="1">&#946;-actin forward (Human)</td><td rowspan="1" colspan="1">GCTGCGTGTGGCTCCCGAGGAG</td></tr><tr><td rowspan="1" colspan="1">&#946;-actin reverse (Human)</td><td rowspan="1" colspan="1">ATCTTCATTGTGCTGGGTGCCAG</td></tr><tr><td rowspan="1" colspan="1">GAPDH forward (Human)</td><td rowspan="1" colspan="1">TCCACCACCCTGTTGCTGTAG</td></tr><tr><td rowspan="1" colspan="1">GAPDH reverse (Human)</td><td rowspan="1" colspan="1">ACCCACTCCTCCACCTTTGAC</td></tr><tr><td rowspan="1" colspan="1">HPRT forward (Mouse)</td><td rowspan="1" colspan="1">TCATTATGCCGAGGATTTGGA</td></tr><tr><td rowspan="1" colspan="1">HPRT reverse (Mouse)</td><td rowspan="1" colspan="1">CAGAGGGCCACAATGTGATG</td></tr><tr><td rowspan="1" colspan="1">Renilla forward</td><td rowspan="1" colspan="1">AGGTGAAGTTCGTCGTCCAACATTATC</td></tr><tr><td rowspan="1" colspan="1">Renilla reverse</td><td rowspan="1" colspan="1">GAAACTTCTTGGCACCTTCAACAATAGC</td></tr><tr><td rowspan="1" colspan="1">18S rRNA forward (Human)</td><td rowspan="1" colspan="1">GTGGAGCGATTTGTCTGGTT</td></tr><tr><td rowspan="1" colspan="1">18S rRNA reverse (Human)</td><td rowspan="1" colspan="1">CGCTGAGCCAGTCAGTGTAG</td></tr><tr><td rowspan="1" colspan="1">28S rRNA forward (Human)</td><td rowspan="1" colspan="1">TGGGTTTTAAGCAGGAGGTG</td></tr><tr><td rowspan="1" colspan="1">28S rRNA reverse (Human)</td><td rowspan="1" colspan="1">AACCTGTCTCACGACGGTCT</td></tr><tr><td rowspan="1" colspan="1">U6 forward (Human)</td><td rowspan="1" colspan="1">CGCTTCGGCAGCACATATAC</td></tr><tr><td rowspan="1" colspan="1">U6 reverse (Human)</td><td rowspan="1" colspan="1">AAAATATGGAACGCTTCACGA</td></tr></tbody>
###xml 722 1419 706 1397 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Primer name</th><th rowspan="1" colspan="1">Primer sequence</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">BDLF1 forward</td><td rowspan="1" colspan="1">CAGATTTGAAAGTGGTAGTGTC</td></tr><tr><td rowspan="1" colspan="1">BDLF1 reverse</td><td rowspan="1" colspan="1">TTATCTTAACCAGCAAGTGGCCG</td></tr><tr><td rowspan="1" colspan="1">&#946;-actin forward (Human)</td><td rowspan="1" colspan="1">GCTGCGTGTGGCTCCCGAGGAG</td></tr><tr><td rowspan="1" colspan="1">&#946;-actin reverse (Human)</td><td rowspan="1" colspan="1">ATCTTCATTGTGCTGGGTGCCAG</td></tr><tr><td rowspan="1" colspan="1">GAPDH forward (Human)</td><td rowspan="1" colspan="1">TCCACCACCCTGTTGCTGTAG</td></tr><tr><td rowspan="1" colspan="1">GAPDH reverse (Human)</td><td rowspan="1" colspan="1">ACCCACTCCTCCACCTTTGAC</td></tr><tr><td rowspan="1" colspan="1">HPRT forward (Mouse)</td><td rowspan="1" colspan="1">TCATTATGCCGAGGATTTGGA</td></tr><tr><td rowspan="1" colspan="1">HPRT reverse (Mouse)</td><td rowspan="1" colspan="1">CAGAGGGCCACAATGTGATG</td></tr><tr><td rowspan="1" colspan="1">Renilla forward</td><td rowspan="1" colspan="1">AGGTGAAGTTCGTCGTCCAACATTATC</td></tr><tr><td rowspan="1" colspan="1">Renilla reverse</td><td rowspan="1" colspan="1">GAAACTTCTTGGCACCTTCAACAATAGC</td></tr><tr><td rowspan="1" colspan="1">18S rRNA forward (Human)</td><td rowspan="1" colspan="1">GTGGAGCGATTTGTCTGGTT</td></tr><tr><td rowspan="1" colspan="1">18S rRNA reverse (Human)</td><td rowspan="1" colspan="1">CGCTGAGCCAGTCAGTGTAG</td></tr><tr><td rowspan="1" colspan="1">28S rRNA forward (Human)</td><td rowspan="1" colspan="1">TGGGTTTTAAGCAGGAGGTG</td></tr><tr><td rowspan="1" colspan="1">28S rRNA reverse (Human)</td><td rowspan="1" colspan="1">AACCTGTCTCACGACGGTCT</td></tr><tr><td rowspan="1" colspan="1">U6 forward (Human)</td><td rowspan="1" colspan="1">CGCTTCGGCAGCACATATAC</td></tr><tr><td rowspan="1" colspan="1">U6 reverse (Human)</td><td rowspan="1" colspan="1">AAAATATGGAACGCTTCACGA</td></tr></tbody></table>
###xml 1419 1420 1397 1398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1419 1514 1397 1492 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="19"><sup>a</sup>Primers for real-time PCR were designed using Beacon designer software (from PREMIER Biosoft).</p>
###xml 1419 1514 1397 1492 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF1"><p textid="19"><sup>a</sup>Primers for real-time PCR were designed using Beacon designer software (from PREMIER Biosoft).</p></fn>
###xml 1419 1514 1397 1492 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF1"><p textid="19"><sup>a</sup>Primers for real-time PCR were designed using Beacon designer software (from PREMIER Biosoft).</p></fn></table-wrap-foot>
###xml 683 1514 667 1492 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="18">PCR primers used in this study<xref ref-type="table-fn" rid="TF1"><bold><sup>a</sup></bold></xref></p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Primer name</th><th rowspan="1" colspan="1">Primer sequence</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">BDLF1 forward</td><td rowspan="1" colspan="1">CAGATTTGAAAGTGGTAGTGTC</td></tr><tr><td rowspan="1" colspan="1">BDLF1 reverse</td><td rowspan="1" colspan="1">TTATCTTAACCAGCAAGTGGCCG</td></tr><tr><td rowspan="1" colspan="1">&#946;-actin forward (Human)</td><td rowspan="1" colspan="1">GCTGCGTGTGGCTCCCGAGGAG</td></tr><tr><td rowspan="1" colspan="1">&#946;-actin reverse (Human)</td><td rowspan="1" colspan="1">ATCTTCATTGTGCTGGGTGCCAG</td></tr><tr><td rowspan="1" colspan="1">GAPDH forward (Human)</td><td rowspan="1" colspan="1">TCCACCACCCTGTTGCTGTAG</td></tr><tr><td rowspan="1" colspan="1">GAPDH reverse (Human)</td><td rowspan="1" colspan="1">ACCCACTCCTCCACCTTTGAC</td></tr><tr><td rowspan="1" colspan="1">HPRT forward (Mouse)</td><td rowspan="1" colspan="1">TCATTATGCCGAGGATTTGGA</td></tr><tr><td rowspan="1" colspan="1">HPRT reverse (Mouse)</td><td rowspan="1" colspan="1">CAGAGGGCCACAATGTGATG</td></tr><tr><td rowspan="1" colspan="1">Renilla forward</td><td rowspan="1" colspan="1">AGGTGAAGTTCGTCGTCCAACATTATC</td></tr><tr><td rowspan="1" colspan="1">Renilla reverse</td><td rowspan="1" colspan="1">GAAACTTCTTGGCACCTTCAACAATAGC</td></tr><tr><td rowspan="1" colspan="1">18S rRNA forward (Human)</td><td rowspan="1" colspan="1">GTGGAGCGATTTGTCTGGTT</td></tr><tr><td rowspan="1" colspan="1">18S rRNA reverse (Human)</td><td rowspan="1" colspan="1">CGCTGAGCCAGTCAGTGTAG</td></tr><tr><td rowspan="1" colspan="1">28S rRNA forward (Human)</td><td rowspan="1" colspan="1">TGGGTTTTAAGCAGGAGGTG</td></tr><tr><td rowspan="1" colspan="1">28S rRNA reverse (Human)</td><td rowspan="1" colspan="1">AACCTGTCTCACGACGGTCT</td></tr><tr><td rowspan="1" colspan="1">U6 forward (Human)</td><td rowspan="1" colspan="1">CGCTTCGGCAGCACATATAC</td></tr><tr><td rowspan="1" colspan="1">U6 reverse (Human)</td><td rowspan="1" colspan="1">AAAATATGGAACGCTTCACGA</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p textid="19"><sup>a</sup>Primers for real-time PCR were designed using Beacon designer software (from PREMIER Biosoft).</p></fn></table-wrap-foot></table-wrap>
###xml 839 844 <span type="species:ncbi:9606">Human</span>
###xml 887 892 <span type="species:ncbi:9606">Human</span>
###xml 931 936 <span type="species:ncbi:9606">Human</span>
###xml 973 978 <span type="species:ncbi:9606">Human</span>
###xml 1014 1019 <span type="species:ncbi:10090">Mouse</span>
###xml 1055 1060 <span type="species:ncbi:10090">Mouse</span>
###xml 1184 1189 <span type="species:ncbi:9606">Human</span>
###xml 1228 1233 <span type="species:ncbi:9606">Human</span>
###xml 1272 1277 <span type="species:ncbi:9606">Human</span>
###xml 1316 1321 <span type="species:ncbi:9606">Human</span>
###xml 1354 1359 <span type="species:ncbi:9606">Human</span>
###xml 1392 1397 <span type="species:ncbi:9606">Human</span>
PCRs were performed using a Taq core kit (Q-Biogen) with a set of specific primer pairs (BDLF1 forward/BDLF1 reverse: Table 1) on various amounts of the RT reaction mixtures (0.05, 0.4, 1 or 2 microl) to have a linearly increasing signal after 25 PCR cycles. The PCR-amplified fragments were then analyzed on 2% agarose gels. We evaluated the endogenous expression of beta-actin mRNA by RT-PCR (beta-actin forward/beta-actin reverse: Table 1). Amplification of a 690-bp DNA fragment corresponding to the beta-actin mature mRNA showed that no DNA contamination was present in our RNA preparations. We tested for the presence of U6 snRNA using RT-PCR (U6 forward/U6 reverse: Table 1). Table 1.PCR primers used in this studyaPrimer namePrimer sequenceBDLF1 forwardCAGATTTGAAAGTGGTAGTGTCBDLF1 reverseTTATCTTAACCAGCAAGTGGCCGbeta-actin forward (Human)GCTGCGTGTGGCTCCCGAGGAGbeta-actin reverse (Human)ATCTTCATTGTGCTGGGTGCCAGGAPDH forward (Human)TCCACCACCCTGTTGCTGTAGGAPDH reverse (Human)ACCCACTCCTCCACCTTTGACHPRT forward (Mouse)TCATTATGCCGAGGATTTGGAHPRT reverse (Mouse)CAGAGGGCCACAATGTGATGRenilla forwardAGGTGAAGTTCGTCGTCCAACATTATCRenilla reverseGAAACTTCTTGGCACCTTCAACAATAGC18S rRNA forward (Human)GTGGAGCGATTTGTCTGGTT18S rRNA reverse (Human)CGCTGAGCCAGTCAGTGTAG28S rRNA forward (Human)TGGGTTTTAAGCAGGAGGTG28S rRNA reverse (Human)AACCTGTCTCACGACGGTCTU6 forward (Human)CGCTTCGGCAGCACATATACU6 reverse (Human)AAAATATGGAACGCTTCACGAaPrimers for real-time PCR were designed using Beacon designer software (from PREMIER Biosoft).
###end p 17
###begin p 18
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 30 31 30 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>a</sup></bold>
###xml 30 31 30 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><bold><sup>a</sup></bold></xref>
PCR primers used in this studya
###end p 18
###begin p 19
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aPrimers for real-time PCR were designed using Beacon designer software (from PREMIER Biosoft).
###end p 19
###begin p 20
###xml 800 801 760 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 801 809 761 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;&#916;Ct</sup>
###xml 817 818 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 967 974 923 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 715 720 <span type="species:ncbi:10090">mouse</span>
For RT-qPCR, a 20 microl reaction was prepared with 5 microl of template cDNA (1/20 diluted), 10 microl of MESA green SYBR premix (Eurogentec), 0.2 microM of each primer and subjected to amplification using a fluorescence thermocycler (Applied Biosystems 7000 RT-PCR, Foster City, CA) under the following conditions: 10 min at 94degreesC for initial denaturation, followed by 40 cycles of denaturation at 95degreesC for 15 s, annealing at 60degreesC for 15 s and elongation at 72degreesC for 30 s. This program was followed by a melting curve analysis in order to verify the specificity of the PCR product. Renilla luciferase was amplified in parallel with the housekeeping gene GAPDH (for HeLa cells) or HPRT (for mouse cells) and relative copy numbers of Renilla cDNAs were compared to GAPDH using x-DeltaCt (where x corresponds to the experimentally calculated amplification efficiency of each primer couple). The primer sequences used in this study (presented in Table 1) were designed using Beacon designer software (from PREMIER Biosoft).
###end p 20
###begin title 21
Western blotting analysis
###end title 21
###begin p 22
###xml 597 599 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 569 575 <span type="species:ncbi:9986">rabbit</span>
###xml 602 606 <span type="species:ncbi:9925">Goat</span>
###xml 612 617 <span type="species:ncbi:10090">mouse</span>
###xml 618 629 <span type="species:ncbi:3704">horseradish</span>
###xml 654 658 <span type="species:ncbi:9925">goat</span>
###xml 664 670 <span type="species:ncbi:9986">rabbit</span>
###xml 671 682 <span type="species:ncbi:3704">horseradish</span>
Cells were collected by centrifugation, lysed on ice for 30 min in 100 microl of HNTG buffer (50 mM HEPES pH 7.5; 150 mM NaCl; 1% Triton X-100; 10% glycerol; 1 mM EDTA; 1 mM phenylmethylsulfonyl fluoride). Proteins were separated on 10% sodium dodecyl sulfate-polyacrylamide electrophoresis gels and then transferred to a nitrocellulose membrane by electroblotting (Hybond-ECL; Amersham Biosciences). Membranes were incubated with, respectively, anti-Flag M2 (Sigma) or anti alpha-tubulin (T5168, Sigma) monoclonal antibodies or an anti-PABP (kind gift from S. Morley) rabbit polyclonal antibody (39). Goat anti-mouse horseradish peroxidase conjugate or goat anti-rabbit horseradish peroxidase conjugate (Amersham) were used at a dilution of 1:5000 as secondary antibodies. For immunoblot detection, the ECL system (Amersham) was used.
###end p 22
###begin title 23
Luciferase assays
###end title 23
###begin p 24
Renilla activity from transfected cells was measured in a Veritastrade mark Luminometer (Turner Biosystems) using the Renilla luciferase assay system (Promega Madison Co). Luciferase activity was measured for identical amounts of total protein as evaluated by Bradford assay.
###end p 24
###begin title 25
Polyribosome fractionation
###end title 25
###begin p 26
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1017 1019 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
Polyribosome fractionation was performed essentially as described previously (40,41). Forty-eight hours after transfection, HEK293T cells were treated with 100 microg/ml cycloheximide at 37degreesC for 5 min and harvested by scraping from the plate. In some experiments, EDTA was added to the cell lysate at a final concentration of 15 mM to disrupt the polysomes. The gradient was collected from the top using a Piston Gradient Fractionator (BioComp, New Brunswick, Canada) with concomitant measurement of the absorbance at 254 nm using an AKTA purifier (GE Healthcare, Amersham Biosciences, Piscataway, NJ) coupled to a fraction collector. For western blotting, 20 microl of each fraction were separated on 12% sodium dodecyl sulfate-polyacrylamide electrophoresis gels and then transferred to a PVDF membrane (Amersham biosciences) by electroblotting. The membrane was then incubated with various antibodies as described above in the 'western blotting analysis' section. RNA extraction was performed as described (15). RNAs were then reverse transcribed and analyzed by quantitative PCR as described above.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin title 28
###xml 39 42 <span type="species:ncbi:10376">EBV</span>
EB2 stimulates protein expression from EBV-derived mRNAs
###end title 28
###begin p 29
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 224 229 224 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26 B27 B28">26&#8211;28</xref>
###xml 779 787 779 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1062 1070 1062 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1156 1164 1156 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1309 1317 1309 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1390 1398 1390 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1524 1532 1524 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1584 1592 1584 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1690 1698 1690 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1804 1812 1804 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1925 1933 1925 1933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2050 2058 2050 2058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2570 2578 2570 2578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2642 2650 2642 2650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2943 2952 2943 2952 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 3016 3017 3016 3017 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 3095 3096 3095 3096 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 3408 3409 3408 3409 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2952 3528 2952 3528 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="30">EB2 stimulates expression of the late EBV viral protein BDLF1. (<bold>A</bold>) Schematic representation of the BDLFI-encoding construct pTRE2-Flag-BDLF1. (<bold>B</bold>) Western analysis of Flag-BDLF1 expression in HeLa cells transfected with pTRE2-Flag-BDLF1, together with pTet-On and an expression plasmid for Flag-EB2 (pCI-FEB2) as indicated in the figure. Doxycycline was added as indicated. The M2 anti-Flag MAb was used to visualize both Flag-BDLF1 and Flag-EB2 proteins. (<bold>C</bold>) Quantification of the BDLF1 cytoplasmic RNA by semi-quantitative RT-PCR in HeLa cells transfected as described above.</p>
###xml 2952 3528 2952 3528 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="30">EB2 stimulates expression of the late EBV viral protein BDLF1. (<bold>A</bold>) Schematic representation of the BDLFI-encoding construct pTRE2-Flag-BDLF1. (<bold>B</bold>) Western analysis of Flag-BDLF1 expression in HeLa cells transfected with pTRE2-Flag-BDLF1, together with pTet-On and an expression plasmid for Flag-EB2 (pCI-FEB2) as indicated in the figure. Doxycycline was added as indicated. The M2 anti-Flag MAb was used to visualize both Flag-BDLF1 and Flag-EB2 proteins. (<bold>C</bold>) Quantification of the BDLF1 cytoplasmic RNA by semi-quantitative RT-PCR in HeLa cells transfected as described above.</p></caption>
###xml 3528 3528 3528 3528 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp497f1"/>
###xml 2943 3528 2943 3528 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="30">EB2 stimulates expression of the late EBV viral protein BDLF1. (<bold>A</bold>) Schematic representation of the BDLFI-encoding construct pTRE2-Flag-BDLF1. (<bold>B</bold>) Western analysis of Flag-BDLF1 expression in HeLa cells transfected with pTRE2-Flag-BDLF1, together with pTet-On and an expression plasmid for Flag-EB2 (pCI-FEB2) as indicated in the figure. Doxycycline was added as indicated. The M2 anti-Flag MAb was used to visualize both Flag-BDLF1 and Flag-EB2 proteins. (<bold>C</bold>) Quantification of the BDLF1 cytoplasmic RNA by semi-quantitative RT-PCR in HeLa cells transfected as described above.</p></caption><graphic xlink:href="gkp497f1"/></fig>
###xml 27 30 <span type="species:ncbi:10376">EBV</span>
###xml 572 575 <span type="species:ncbi:10376">EBV</span>
###xml 758 761 <span type="species:ncbi:10376">EBV</span>
###xml 2990 2993 <span type="species:ncbi:10376">EBV</span>
It has been shown that the EBV-encoded viral protein EB2 acts as a nuclear export factor for a particular subset of mRNAs generated from intronless genes and for some unspliced mRNAs derived from intron-containing genes (24,26-28). However, although EB2 probably shuttles from the nucleus to the cytoplasm together with the exported RNA, the effect of EB2 on mRNA translation has never been reported. This prompted us to test whether expression of EB2 could have an influence on translation of its target viral mRNAs. We thus tested the effect of EB2 on translation of an EBV-encoded mRNA whose cytoplasmic accumulation depends on EB2. In order to control transcription of the target mRNA, we used the Tet-On gene expression system (Clontech) to express the EBV BDLF1 late mRNA (Figure 1A). For this, the pTRE2-Flag-BDLF1 plasmid was transfected into HeLa cells together with the pTet-On vector (Clontech) and with or without the EB2 expression plasmid. Expression of EB2 and the BDLF1 protein was then monitored by western blotting using an anti-Flag antibody (Figure 1B). The amount of cytoplasmic BDLF1 mRNAs was quantified by semi-quantitative RT-PCR (Figure 1C). In cells cotransfected with the BDLF1 reporter plasmid and the pTet-On vector, in the absence of doxycycline, no BDLF1 protein was detected (Figure 1B, lane 4) and only a low amount of BDLF1 mRNAs were detected by RT-PCR (Figure 1C, lane 4). In these conditions, the expression of EB2 enhanced the cytoplasmic accumulation of the corresponding BDLF1 mRNA (Figure 1C, lane 6) but again no BDLF1 protein was detected (Figure 1B, lane 6). When doxycycline was added, the transcription of BDLF1 mRNAs was strongly stimulated (Figure 1C, lane 3) although only low levels of BDLF1 protein were detected by western blot in the absence of EB2 (Figure 1B, lane 3). However, in the presence of EB2 there was a large increase in the amount of BDLF1 protein expressed (Figure 1B, lane 5) although the amount of BDLF1 mRNA detected in the cytoplasm was comparable to that in the absence of EB2 (Figure 1C, compare lanes 3 and 5). Indeed, in these conditions, transcription of BDLF1 triggered by doxycycline was so strong that it appeared to compensate for the otherwise poor cytoplasmic accumulation observed in the absence of EB2. This allowed us to focus just on the effect of EB2 on BDLF1 translation without introducing a bias with the amount of mRNA. Finally, upon addition of doxycycline, only a weak signal corresponding to the BDLF1 mRNA expression was detected by RT-PCR in the absence or presence of EB2 (Figure 1C, lanes 1 and 2) and no BDLF1 protein expression was detected (Figure 1B, lanes 1 and 2) thus ruling out any non-specific effect of doxyxycline on BDLF1 expression in the absence of the pTet-On vector. Essentially similar results were obtained using the Tet-Off system for which transcription of BDLF1 was triggered by the absence of doxycycline (data not shown). Figure 1.EB2 stimulates expression of the late EBV viral protein BDLF1. (A) Schematic representation of the BDLFI-encoding construct pTRE2-Flag-BDLF1. (B) Western analysis of Flag-BDLF1 expression in HeLa cells transfected with pTRE2-Flag-BDLF1, together with pTet-On and an expression plasmid for Flag-EB2 (pCI-FEB2) as indicated in the figure. Doxycycline was added as indicated. The M2 anti-Flag MAb was used to visualize both Flag-BDLF1 and Flag-EB2 proteins. (C) Quantification of the BDLF1 cytoplasmic RNA by semi-quantitative RT-PCR in HeLa cells transfected as described above.
###end p 29
###begin p 30
###xml 64 65 64 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 143 144 143 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 456 457 456 457 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 38 41 <span type="species:ncbi:10376">EBV</span>
EB2 stimulates expression of the late EBV viral protein BDLF1. (A) Schematic representation of the BDLFI-encoding construct pTRE2-Flag-BDLF1. (B) Western analysis of Flag-BDLF1 expression in HeLa cells transfected with pTRE2-Flag-BDLF1, together with pTet-On and an expression plasmid for Flag-EB2 (pCI-FEB2) as indicated in the figure. Doxycycline was added as indicated. The M2 anti-Flag MAb was used to visualize both Flag-BDLF1 and Flag-EB2 proteins. (C) Quantification of the BDLF1 cytoplasmic RNA by semi-quantitative RT-PCR in HeLa cells transfected as described above.
###end p 30
###begin p 31
###xml 85 88 <span type="species:ncbi:10376">EBV</span>
These results strongly suggest that EB2 is able to stimulate protein expression from EBV-derived mRNAs.
###end p 31
###begin title 32
###xml 63 66 <span type="species:ncbi:10376">EBV</span>
EB2 stimulates both export and translation independently of an EBV-specific sequence without affecting global mRNA translation
###end title 32
###begin p 33
###xml 286 294 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 540 548 537 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 551 560 548 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 621 629 618 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 808 816 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1223 1231 1220 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1234 1246 1231 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">middle panel</italic>
###xml 1304 1312 1301 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1315 1324 1312 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 1751 1759 1748 1756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1762 1774 1759 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom panel</italic>
###xml 1777 1786 1774 1783 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 1926 1927 1923 1924 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2104 2105 2101 2102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2415 2416 2412 2413 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2629 2636 2626 2633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 2673 2674 2670 2671 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1786 3164 1783 3161 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34">EB2 stimulates expression of a Renilla luciferase intronless gene at the translational level, independently of any viral-derived sequence. (<bold>A</bold>) Schematic representation of the luciferase intronless coding vector used in this study (pcDNAGlobinRen) showing positions of the CMV promoter and BGH polyadenylation signal. (<bold>B</bold>) Immunoblot of HeLa cells cotransfected with pcDNAGlobinRen together with the empty pCI vector or increasing amounts of the FlagEB2-encoding plasmid, pCI-FlagEB2 (250 and 500 ng). The M2 anti-Flag MAb was used to visualize Flag-EB2. Asterisk denotes an unspecific band detected by the M2 anti-Flag antibody. (<bold>C</bold>) Quantification of the amount of U6 snRNA present respectively in the nuclear and cytoplasmic fractions of cellular extracts used in D. U6 snRNA was amplified by RT-PCR using the specific primer set indicated in <xref ref-type="table" rid="T1">Table 1</xref>, and analyzed on a 2% agarose gel. (<bold>D</bold>) Measure of luciferase activity and quantification of cytoplasmic luciferase-encoding mRNAs by quantitative RT-PCR using GAPDH as an internal control. Total luciferase activity was measured 24 h post-transfection (top panel) and the amount of cytoplasmic luciferase coding mRNAs was quantified (middle panel). Translational efficiency (bottom panel) was calculated by normalizing the total luciferase activity by reference to the amount of cytoplasmic luciferase mRNA. AU: arbitrary units.</p>
###xml 1786 3164 1783 3161 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="34">EB2 stimulates expression of a Renilla luciferase intronless gene at the translational level, independently of any viral-derived sequence. (<bold>A</bold>) Schematic representation of the luciferase intronless coding vector used in this study (pcDNAGlobinRen) showing positions of the CMV promoter and BGH polyadenylation signal. (<bold>B</bold>) Immunoblot of HeLa cells cotransfected with pcDNAGlobinRen together with the empty pCI vector or increasing amounts of the FlagEB2-encoding plasmid, pCI-FlagEB2 (250 and 500 ng). The M2 anti-Flag MAb was used to visualize Flag-EB2. Asterisk denotes an unspecific band detected by the M2 anti-Flag antibody. (<bold>C</bold>) Quantification of the amount of U6 snRNA present respectively in the nuclear and cytoplasmic fractions of cellular extracts used in D. U6 snRNA was amplified by RT-PCR using the specific primer set indicated in <xref ref-type="table" rid="T1">Table 1</xref>, and analyzed on a 2% agarose gel. (<bold>D</bold>) Measure of luciferase activity and quantification of cytoplasmic luciferase-encoding mRNAs by quantitative RT-PCR using GAPDH as an internal control. Total luciferase activity was measured 24 h post-transfection (top panel) and the amount of cytoplasmic luciferase coding mRNAs was quantified (middle panel). Translational efficiency (bottom panel) was calculated by normalizing the total luciferase activity by reference to the amount of cytoplasmic luciferase mRNA. AU: arbitrary units.</p></caption>
###xml 3164 3164 3161 3161 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp497f2"/>
###xml 1777 3164 1774 3161 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="34">EB2 stimulates expression of a Renilla luciferase intronless gene at the translational level, independently of any viral-derived sequence. (<bold>A</bold>) Schematic representation of the luciferase intronless coding vector used in this study (pcDNAGlobinRen) showing positions of the CMV promoter and BGH polyadenylation signal. (<bold>B</bold>) Immunoblot of HeLa cells cotransfected with pcDNAGlobinRen together with the empty pCI vector or increasing amounts of the FlagEB2-encoding plasmid, pCI-FlagEB2 (250 and 500 ng). The M2 anti-Flag MAb was used to visualize Flag-EB2. Asterisk denotes an unspecific band detected by the M2 anti-Flag antibody. (<bold>C</bold>) Quantification of the amount of U6 snRNA present respectively in the nuclear and cytoplasmic fractions of cellular extracts used in D. U6 snRNA was amplified by RT-PCR using the specific primer set indicated in <xref ref-type="table" rid="T1">Table 1</xref>, and analyzed on a 2% agarose gel. (<bold>D</bold>) Measure of luciferase activity and quantification of cytoplasmic luciferase-encoding mRNAs by quantitative RT-PCR using GAPDH as an internal control. Total luciferase activity was measured 24 h post-transfection (top panel) and the amount of cytoplasmic luciferase coding mRNAs was quantified (middle panel). Translational efficiency (bottom panel) was calculated by normalizing the total luciferase activity by reference to the amount of cytoplasmic luciferase mRNA. AU: arbitrary units.</p></caption><graphic xlink:href="gkp497f2"/></fig>
###xml 141 146 <span type="species:ncbi:9606">human</span>
###xml 255 258 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 363 366 <span type="species:ncbi:10376">EBV</span>
###xml 2058 2061 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
In order to quantify the relative effects of EB2 on mRNA export and translation we designed a reporter construct containing the 5'UTR of the human beta-Globin gene followed by the Renilla luciferase coding region under the control of the cytomegalovirus (CMV) immediate early promoter (Figure 2A). It is important to note that this construct does not contain any EBV-related sequence. This construct was cotransfected together with the EB2 expression vector in HeLa cells and total luciferase activity was analyzed 24 h after transfection (Figure 2D, top panel), while expression of EB2 was measured by western blotting (Figure 2B). Cytoplasmic RNAs were extracted and we first quantified the amount of U6 snRNA in order to make sure that our cytoplasmic fractions were not contaminated by nuclear material (Figure 2C). Then cytoplasmic luciferase RNAs were quantified by relative quantitative RT-PCR using the housekeeping gene GAPDH as an internal control (). Interestingly, EB2 had no effect on GAPDH mRNA export thus ruling out any bias in the relative quantification of luciferase-coding mRNAs. As expected, expression of EB2 promoted the cytoplasmic accumulation of luciferase-coding RNAs in a dose-dependent manner (Figure 2D, middle panel) thus leading to a stimulation of luciferase expression (Figure 2D, top panel). The luciferase activity measured in each assay was then normalized to the amount of luciferase cytoplasmic RNAs. This gives an exact measure of the luciferase activity per RNA molecule, and thus can be considered as a quantitative representation of the translation rate. Interestingly, using this quantification we found that an average 7-fold stimulation of luciferase mRNA translation in the presence of EB2 was observed (Figure 2D, bottom panel). Figure 2.EB2 stimulates expression of a Renilla luciferase intronless gene at the translational level, independently of any viral-derived sequence. (A) Schematic representation of the luciferase intronless coding vector used in this study (pcDNAGlobinRen) showing positions of the CMV promoter and BGH polyadenylation signal. (B) Immunoblot of HeLa cells cotransfected with pcDNAGlobinRen together with the empty pCI vector or increasing amounts of the FlagEB2-encoding plasmid, pCI-FlagEB2 (250 and 500 ng). The M2 anti-Flag MAb was used to visualize Flag-EB2. Asterisk denotes an unspecific band detected by the M2 anti-Flag antibody. (C) Quantification of the amount of U6 snRNA present respectively in the nuclear and cytoplasmic fractions of cellular extracts used in D. U6 snRNA was amplified by RT-PCR using the specific primer set indicated in Table 1, and analyzed on a 2% agarose gel. (D) Measure of luciferase activity and quantification of cytoplasmic luciferase-encoding mRNAs by quantitative RT-PCR using GAPDH as an internal control. Total luciferase activity was measured 24 h post-transfection (top panel) and the amount of cytoplasmic luciferase coding mRNAs was quantified (middle panel). Translational efficiency (bottom panel) was calculated by normalizing the total luciferase activity by reference to the amount of cytoplasmic luciferase mRNA. AU: arbitrary units.
###end p 33
###begin p 34
###xml 140 141 140 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 318 319 318 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 629 630 629 630 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 843 850 843 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 887 888 887 888 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 272 275 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
EB2 stimulates expression of a Renilla luciferase intronless gene at the translational level, independently of any viral-derived sequence. (A) Schematic representation of the luciferase intronless coding vector used in this study (pcDNAGlobinRen) showing positions of the CMV promoter and BGH polyadenylation signal. (B) Immunoblot of HeLa cells cotransfected with pcDNAGlobinRen together with the empty pCI vector or increasing amounts of the FlagEB2-encoding plasmid, pCI-FlagEB2 (250 and 500 ng). The M2 anti-Flag MAb was used to visualize Flag-EB2. Asterisk denotes an unspecific band detected by the M2 anti-Flag antibody. (C) Quantification of the amount of U6 snRNA present respectively in the nuclear and cytoplasmic fractions of cellular extracts used in D. U6 snRNA was amplified by RT-PCR using the specific primer set indicated in Table 1, and analyzed on a 2% agarose gel. (D) Measure of luciferase activity and quantification of cytoplasmic luciferase-encoding mRNAs by quantitative RT-PCR using GAPDH as an internal control. Total luciferase activity was measured 24 h post-transfection (top panel) and the amount of cytoplasmic luciferase coding mRNAs was quantified (middle panel). Translational efficiency (bottom panel) was calculated by normalizing the total luciferase activity by reference to the amount of cytoplasmic luciferase mRNA. AU: arbitrary units.
###end p 34
###begin p 35
###xml 341 349 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 490 499 490 499 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 672 673 672 673 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1006 1007 1006 1007 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1126 1128 1126 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1331 1332 1331 1332 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 499 1929 499 1929 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="36">EB2 does not affect protein stability or global cellular mRNA translation and its effect on translation is independent of the amount of cytoplasmic luciferase coding mRNA. (<bold>A</bold>) Time-lapse measure of total luciferase activity from HeLa cells mock transfected (pCI) or transfected with an EB2 expression vector (pCI-FlagEB2) (250 ng) after addition of cycloheximide to block translation. Luciferase activity was measured 0, 15, 30, 60, 120, 180 and 240 min after addition of cycloheximide to the cell medium. (<bold>B</bold>) Metabolic labeling of HeLa cells mock transfected (pCI) or transfected with the EB2-encoding plasmid (250 ng), using <sup>35</sup>S-labeled methionine. After a 30-min pulse labeling, cells were lyzed and total cellular proteins resolved on 12% SDS-PAGE. Total translation was quantified by phosphorimaging using a Fujifilm FLA5100. (<bold>C</bold>) Top panel: Luciferase activity was plotted against the amount of cytoplasmic luciferase coding mRNAs in HeLa cells transfected with increasing amounts of luciferase-encoding plasmid in the absence (pCI) or presence (pCI-FlagEB2) of EB2 (250 and 500 ng). Bottom panel: Translation rates per unit of luciferase-encoding mRNAs (calculated by normalizing luciferase activity by reference to the amount of cytoplasmic luciferase-encoding mRNAs) in HeLa cells transfected with increasing amounts of luciferase-encoding plasmid in the absence or presence of EB2 expression plasmid. AU: arbitrary units.</p>
###xml 499 1929 499 1929 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="36">EB2 does not affect protein stability or global cellular mRNA translation and its effect on translation is independent of the amount of cytoplasmic luciferase coding mRNA. (<bold>A</bold>) Time-lapse measure of total luciferase activity from HeLa cells mock transfected (pCI) or transfected with an EB2 expression vector (pCI-FlagEB2) (250 ng) after addition of cycloheximide to block translation. Luciferase activity was measured 0, 15, 30, 60, 120, 180 and 240 min after addition of cycloheximide to the cell medium. (<bold>B</bold>) Metabolic labeling of HeLa cells mock transfected (pCI) or transfected with the EB2-encoding plasmid (250 ng), using <sup>35</sup>S-labeled methionine. After a 30-min pulse labeling, cells were lyzed and total cellular proteins resolved on 12% SDS-PAGE. Total translation was quantified by phosphorimaging using a Fujifilm FLA5100. (<bold>C</bold>) Top panel: Luciferase activity was plotted against the amount of cytoplasmic luciferase coding mRNAs in HeLa cells transfected with increasing amounts of luciferase-encoding plasmid in the absence (pCI) or presence (pCI-FlagEB2) of EB2 (250 and 500 ng). Bottom panel: Translation rates per unit of luciferase-encoding mRNAs (calculated by normalizing luciferase activity by reference to the amount of cytoplasmic luciferase-encoding mRNAs) in HeLa cells transfected with increasing amounts of luciferase-encoding plasmid in the absence or presence of EB2 expression plasmid. AU: arbitrary units.</p></caption>
###xml 1929 1929 1929 1929 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp497f3"/>
###xml 490 1929 490 1929 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="36">EB2 does not affect protein stability or global cellular mRNA translation and its effect on translation is independent of the amount of cytoplasmic luciferase coding mRNA. (<bold>A</bold>) Time-lapse measure of total luciferase activity from HeLa cells mock transfected (pCI) or transfected with an EB2 expression vector (pCI-FlagEB2) (250 ng) after addition of cycloheximide to block translation. Luciferase activity was measured 0, 15, 30, 60, 120, 180 and 240 min after addition of cycloheximide to the cell medium. (<bold>B</bold>) Metabolic labeling of HeLa cells mock transfected (pCI) or transfected with the EB2-encoding plasmid (250 ng), using <sup>35</sup>S-labeled methionine. After a 30-min pulse labeling, cells were lyzed and total cellular proteins resolved on 12% SDS-PAGE. Total translation was quantified by phosphorimaging using a Fujifilm FLA5100. (<bold>C</bold>) Top panel: Luciferase activity was plotted against the amount of cytoplasmic luciferase coding mRNAs in HeLa cells transfected with increasing amounts of luciferase-encoding plasmid in the absence (pCI) or presence (pCI-FlagEB2) of EB2 (250 and 500 ng). Bottom panel: Translation rates per unit of luciferase-encoding mRNAs (calculated by normalizing luciferase activity by reference to the amount of cytoplasmic luciferase-encoding mRNAs) in HeLa cells transfected with increasing amounts of luciferase-encoding plasmid in the absence or presence of EB2 expression plasmid. AU: arbitrary units.</p></caption><graphic xlink:href="gkp497f3"/></fig>
To test any impact EB2 could have on the stability of the neosynthesized luciferase protein we analyzed the stability of the luciferase protein in the absence and presence of EB2. For this, we blocked cellular translation by adding cycloheximide and measured luciferase decay activity over time on cells expressing, or not, EB2. As shown in Figure 3A, EB2 did not affect the stability of the Renilla luciferase protein, which had a 30-min half-life both in the absence and presence of EB2. Figure 3.EB2 does not affect protein stability or global cellular mRNA translation and its effect on translation is independent of the amount of cytoplasmic luciferase coding mRNA. (A) Time-lapse measure of total luciferase activity from HeLa cells mock transfected (pCI) or transfected with an EB2 expression vector (pCI-FlagEB2) (250 ng) after addition of cycloheximide to block translation. Luciferase activity was measured 0, 15, 30, 60, 120, 180 and 240 min after addition of cycloheximide to the cell medium. (B) Metabolic labeling of HeLa cells mock transfected (pCI) or transfected with the EB2-encoding plasmid (250 ng), using 35S-labeled methionine. After a 30-min pulse labeling, cells were lyzed and total cellular proteins resolved on 12% SDS-PAGE. Total translation was quantified by phosphorimaging using a Fujifilm FLA5100. (C) Top panel: Luciferase activity was plotted against the amount of cytoplasmic luciferase coding mRNAs in HeLa cells transfected with increasing amounts of luciferase-encoding plasmid in the absence (pCI) or presence (pCI-FlagEB2) of EB2 (250 and 500 ng). Bottom panel: Translation rates per unit of luciferase-encoding mRNAs (calculated by normalizing luciferase activity by reference to the amount of cytoplasmic luciferase-encoding mRNAs) in HeLa cells transfected with increasing amounts of luciferase-encoding plasmid in the absence or presence of EB2 expression plasmid. AU: arbitrary units.
###end p 35
###begin p 36
###xml 173 174 173 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 507 508 507 508 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 627 629 627 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 832 833 832 833 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
EB2 does not affect protein stability or global cellular mRNA translation and its effect on translation is independent of the amount of cytoplasmic luciferase coding mRNA. (A) Time-lapse measure of total luciferase activity from HeLa cells mock transfected (pCI) or transfected with an EB2 expression vector (pCI-FlagEB2) (250 ng) after addition of cycloheximide to block translation. Luciferase activity was measured 0, 15, 30, 60, 120, 180 and 240 min after addition of cycloheximide to the cell medium. (B) Metabolic labeling of HeLa cells mock transfected (pCI) or transfected with the EB2-encoding plasmid (250 ng), using 35S-labeled methionine. After a 30-min pulse labeling, cells were lyzed and total cellular proteins resolved on 12% SDS-PAGE. Total translation was quantified by phosphorimaging using a Fujifilm FLA5100. (C) Top panel: Luciferase activity was plotted against the amount of cytoplasmic luciferase coding mRNAs in HeLa cells transfected with increasing amounts of luciferase-encoding plasmid in the absence (pCI) or presence (pCI-FlagEB2) of EB2 (250 and 500 ng). Bottom panel: Translation rates per unit of luciferase-encoding mRNAs (calculated by normalizing luciferase activity by reference to the amount of cytoplasmic luciferase-encoding mRNAs) in HeLa cells transfected with increasing amounts of luciferase-encoding plasmid in the absence or presence of EB2 expression plasmid. AU: arbitrary units.
###end p 36
###begin p 37
###xml 232 240 232 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 447 455 447 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 25 28 <span type="species:ncbi:10376">EBV</span>
Furthermore, the lack of EBV-derived sequences on the luciferase reporter construct prompted us to test the effect of EB2 on global cellular mRNA translation. We thus performed a metabolic labeling of cells expressing (or not) EB2 (Figure 3B). For this, cells were pulsed in the presence of radiolabeled methionine for 30 min. Cells were then lysed and proteins resolved on SDS-PAGE to quantify the overall cellular translation rates. As shown in Figure 3B, we did not detect any significant difference in translation rates between cells expressing EB2 and those not expressing EB2.
###end p 37
###begin p 38
###xml 426 428 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 429 431 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 511 513 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
We also wanted to exclude the possibility that translation stimulation driven by EB2 depends on protein kinase R (PKR). PKR is the principal cellular factor involved in the interferon-mediated inhibition of viral translation. This kinase is activated by double-stranded RNA and this activation leads to the phosphorylation of initiation factor eIF2alpha, thus inhibiting translation initiation of all cellular and viral RNAs (42,43). We thus monitored luciferase translation both in NIH3T3 PKR-deficient cells (36) and wt NIH3T3 in the presence or absence of EB2. We found that EB2 was able to stimulate translation of luciferase coding mRNAs even in the absence of PKR (), which argues for a mechanism of translation stimulation independent of the PKR pathway.
###end p 38
###begin p 39
###xml 295 303 295 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 710 718 710 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 742 751 742 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 1196 1208 1196 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom panel</italic>
Finally, to rule out the possibility that translation rates were affected by the amount of cytoplasmic mRNAs, thus leading to a stimulation of translation which would be independent of EB2, we transfected increasing amounts of luciferase expression vector in HeLa cells expressing, or not, EB2 (Figure 3C). As EB2 expression leads to a 4-5-fold increase of mRNA levels in the cytoplasm, it was of interest to test if increasing the amount of luciferase mRNAs in the absence of EB2 could lead to a stimulation of translation. For this, we measured luciferase translation rates (luciferase activity/amount of luciferase mRNA) for increasing amounts of cytoplasmic mRNAs either in the presence or absence of EB2 (Figure 3C). As presented in the top panel, luciferase expression increased proportionally with the amount of cytoplasmic mRNAs, both in the presence and absence of EB2. However, when luciferase activity was normalized to the amount of cytoplasmic mRNAs (which corresponds to the translation rate per arbitrary unit of mRNA) there was no significant change in luciferase translation rates for increasing amounts of cytoplasmic luciferase mRNAs in control (pCI) and EB2-expressing cells (bottom panel). Nevertheless, translation rates in the presence of EB2 were systematically 4-5-fold more than those in the absence of EB2, and this for identical mRNA amounts measured in the cytoplasm of the cells.
###end p 39
###begin p 40
Taken together, these results show that EB2 stimulates translation of mRNAs without affecting the stability of the neosynthesized protein. Interestingly, EB2 expression does not affect global mRNA translation. Moreover, translation stimulation does not depend on the amount of cytoplasmic mRNA available for translation.
###end p 40
###begin title 41
Addition of an intron within the reporter construct impairs translation stimulation driven by EB2
###end title 41
###begin p 42
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 601 609 598 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 787 795 784 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1052 1060 1049 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1355 1363 1352 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1583 1592 1580 1589 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1652 1653 1649 1650 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2004 2005 1998 1999 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2303 2304 2297 2298 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1592 2604 1589 2598 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">Translation stimulation does not occur with spliced mRNAs. (<bold>A</bold>) Schematic representation of the intronless (pcDNAGlobinRen) and the intron-containing (pcDNAIntronGlobinRen) vectors encoding the Renilla luciferase showing positions of the human &#946;-globin intron within the 5&#8242;UTR of the luciferase construct (gray arrows correspond to positions of the PCR primers used to test efficient splicing of the intron). (<bold>B</bold>) RT-PCR (using primers shown in A) from cells cotransfected with pcDNAGlobinRen and pCI or the EB2-encoding plasmid pCI-FlagEB2 (lanes 2 and 3) or from cells cotransfected with pcDNAIntronGlobinRen and pCI or pCI-FlagEB2 (lanes 5 and 6), or directly from the purified DNA vector (lanes 4 and 7). (<bold>C</bold>) Luciferase activity normalized by reference to the amount of cytoplasmic luciferase-encoding mRNAs from HeLa cells cotransfected with pcDNAGlobinRen and pCI or pCI-FlagEB2, or pcDNAIntronGlobinRen and pCI or pCI-FlagEB2. The amount of luciferase-encoding mRNAs was monitored by quantitative RT-PCR.</p>
###xml 1592 2604 1589 2598 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="43">Translation stimulation does not occur with spliced mRNAs. (<bold>A</bold>) Schematic representation of the intronless (pcDNAGlobinRen) and the intron-containing (pcDNAIntronGlobinRen) vectors encoding the Renilla luciferase showing positions of the human &#946;-globin intron within the 5&#8242;UTR of the luciferase construct (gray arrows correspond to positions of the PCR primers used to test efficient splicing of the intron). (<bold>B</bold>) RT-PCR (using primers shown in A) from cells cotransfected with pcDNAGlobinRen and pCI or the EB2-encoding plasmid pCI-FlagEB2 (lanes 2 and 3) or from cells cotransfected with pcDNAIntronGlobinRen and pCI or pCI-FlagEB2 (lanes 5 and 6), or directly from the purified DNA vector (lanes 4 and 7). (<bold>C</bold>) Luciferase activity normalized by reference to the amount of cytoplasmic luciferase-encoding mRNAs from HeLa cells cotransfected with pcDNAGlobinRen and pCI or pCI-FlagEB2, or pcDNAIntronGlobinRen and pCI or pCI-FlagEB2. The amount of luciferase-encoding mRNAs was monitored by quantitative RT-PCR.</p></caption>
###xml 2604 2604 2598 2598 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp497f4"/>
###xml 1583 2604 1580 2598 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="43">Translation stimulation does not occur with spliced mRNAs. (<bold>A</bold>) Schematic representation of the intronless (pcDNAGlobinRen) and the intron-containing (pcDNAIntronGlobinRen) vectors encoding the Renilla luciferase showing positions of the human &#946;-globin intron within the 5&#8242;UTR of the luciferase construct (gray arrows correspond to positions of the PCR primers used to test efficient splicing of the intron). (<bold>B</bold>) RT-PCR (using primers shown in A) from cells cotransfected with pcDNAGlobinRen and pCI or the EB2-encoding plasmid pCI-FlagEB2 (lanes 2 and 3) or from cells cotransfected with pcDNAIntronGlobinRen and pCI or pCI-FlagEB2 (lanes 5 and 6), or directly from the purified DNA vector (lanes 4 and 7). (<bold>C</bold>) Luciferase activity normalized by reference to the amount of cytoplasmic luciferase-encoding mRNAs from HeLa cells cotransfected with pcDNAGlobinRen and pCI or pCI-FlagEB2, or pcDNAIntronGlobinRen and pCI or pCI-FlagEB2. The amount of luciferase-encoding mRNAs was monitored by quantitative RT-PCR.</p></caption><graphic xlink:href="gkp497f4"/></fig>
###xml 1829 1834 <span type="species:ncbi:9606">human</span>
Our results show that EB2 is able to stimulate translation of viral genes and that of a non-related reporter gene without affecting global cellular translation. Consequently, we focused on understanding the lack of an effect of EB2 on cellular mRNA translation. Interestingly, EB2 has been shown to specifically stimulate the nuclear export of mRNA generated from intronless genes (23). This prompted us to test the translation of an mRNA generated from an intron-containing gene in the presence of EB2. We have thus introduced the beta-globin intron within the 5'UTR of the luciferase reporter gene (Figure 4A). In order to test the efficiency of splicing of the corresponding mRNA, an RT-PCR from cytoplasmic mRNAs was performed using a forward and reverse primer flanking the intron (Figure 4B). We observed that transfection of the intronless construct in HeLa cells led to the expression of an unspliced mRNA which, upon RT-PCR, yielded a band of the same size to that from the control PCR, performed directly using the DNA plasmid as a template (Figure 4B, lanes 2, 3 and 4). On the contrary, transfection of the intron-containing construct led to the expression of an mRNA which, upon RT-PCR, yielded a band slightly longer than that of the intronless mRNA, but shorter than that of the control PCR obtained from the intron-containing DNA plasmid (Figure 4B, lanes 5-7). This band corresponds to the spliced form of the luciferase-coding mRNA. Thus the mRNA transcribed from this intron-containing reporter gene was efficiently spliced both in the presence or absence of EB2. Figure 4.Translation stimulation does not occur with spliced mRNAs. (A) Schematic representation of the intronless (pcDNAGlobinRen) and the intron-containing (pcDNAIntronGlobinRen) vectors encoding the Renilla luciferase showing positions of the human beta-globin intron within the 5'UTR of the luciferase construct (gray arrows correspond to positions of the PCR primers used to test efficient splicing of the intron). (B) RT-PCR (using primers shown in A) from cells cotransfected with pcDNAGlobinRen and pCI or the EB2-encoding plasmid pCI-FlagEB2 (lanes 2 and 3) or from cells cotransfected with pcDNAIntronGlobinRen and pCI or pCI-FlagEB2 (lanes 5 and 6), or directly from the purified DNA vector (lanes 4 and 7). (C) Luciferase activity normalized by reference to the amount of cytoplasmic luciferase-encoding mRNAs from HeLa cells cotransfected with pcDNAGlobinRen and pCI or pCI-FlagEB2, or pcDNAIntronGlobinRen and pCI or pCI-FlagEB2. The amount of luciferase-encoding mRNAs was monitored by quantitative RT-PCR.
###end p 42
###begin p 43
###xml 60 61 60 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 412 413 409 410 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 711 712 708 709 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 237 242 <span type="species:ncbi:9606">human</span>
Translation stimulation does not occur with spliced mRNAs. (A) Schematic representation of the intronless (pcDNAGlobinRen) and the intron-containing (pcDNAIntronGlobinRen) vectors encoding the Renilla luciferase showing positions of the human beta-globin intron within the 5'UTR of the luciferase construct (gray arrows correspond to positions of the PCR primers used to test efficient splicing of the intron). (B) RT-PCR (using primers shown in A) from cells cotransfected with pcDNAGlobinRen and pCI or the EB2-encoding plasmid pCI-FlagEB2 (lanes 2 and 3) or from cells cotransfected with pcDNAIntronGlobinRen and pCI or pCI-FlagEB2 (lanes 5 and 6), or directly from the purified DNA vector (lanes 4 and 7). (C) Luciferase activity normalized by reference to the amount of cytoplasmic luciferase-encoding mRNAs from HeLa cells cotransfected with pcDNAGlobinRen and pCI or pCI-FlagEB2, or pcDNAIntronGlobinRen and pCI or pCI-FlagEB2. The amount of luciferase-encoding mRNAs was monitored by quantitative RT-PCR.
###end p 43
###begin p 44
###xml 266 274 266 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 847 852 847 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
We then quantified the exact amount of cytoplasmic luciferase mRNA by quantitative RT-PCR and measured the corresponding luciferase activities (). When translation rates were calculated by normalizing the luciferase activity to the amount of luciferase-coding mRNA (Figure 4C), we observed a 10-fold more efficient translation of the spliced mRNA compared to unspliced in the absence of EB2. As expected, in the presence of EB2 the translation rate of the unspliced mRNA was increased by a factor 6. However, expression of EB2 did not further stimulate translation of the spliced luciferase mRNA but rather led to a mild inhibition. It is noteworthy, that we also observed an inhibitory effect of EB2 on the accumulation of luciferase mRNA generated from the intron-containing construct () which corroborates previously published data from Ruvolo et al. (44).
###end p 44
###begin p 45
These results indicate that EB2 specifically stimulates translation of intronless mRNAs without significantly affecting translation of spliced mRNAs.
###end p 45
###begin title 46
EB2 co-sediments with polyribosomes and increases the utilization of reporter mRNA by the translation machinery
###end title 46
###begin p 47
###xml 612 620 612 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 694 702 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 909 917 909 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1433 1441 1429 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1451 1460 1447 1456 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1570 1571 1566 1567 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1573 1574 1569 1570 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1579 1580 1575 1576 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2515 2516 2507 2508 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2518 2519 2510 2511 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 2524 2525 2516 2517 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1460 3011 1456 3003 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">EB2 cosediments with polyribosomes and enhances utilization of its target mRNA by the translation machinery. (<bold>A</bold>, <bold>B</bold> and <bold>C</bold>) Cell cytosolic extracts of HEK293T transfected with pcDNAGlobinRen alone or pcDNAGlobinRen together with pCI-Flag.EB2 or pcDNAIntron-GlobinRen alone, were fractionated across 10&#8211;50% sucrose gradients. (A) Fractions from the gradient corresponding to HEK293T transfected with pcDNAGlobinRen together with pCI-Flag.EB2 were analyzed by western blotting with antibodies against the Flag epitope to detect Flag.EB2, poly(A)-binding protein (PABP) or &#945;-tubulin. (Top) UV absorbance (254 nm) profile of cytoplasmic ribonucleoprotein complexes. (B) 18S and 28S RNA profile determined by quantitative RT-PCR. (C) Quantification of the Renilla luciferase reporter mRNA fractionated across 10&#8211;50% sucrose gradients by quantitative RT-PCR. (Top panel) HEK293T transfected with pcDNAGlobinRen. (Middle panel) HEK293T transfected with pcDNAGlobinRen together with pCI-Flag.EB2. (Bottom panel) HEK293T transfected with pcDNAIntron-GlobinRen. (<bold>D</bold>, <bold>E</bold> and <bold>F</bold>) An EDTA-treated cytoplasmic extract of HEK 293T cells transfected with pcDNAGlobinRen together with pCIF.EB2 was fractionated across a 10&#8211;50% sucrose gradients. (D) EB2 is relocalized to the top of the gradient. (Top) UV absorbance (254 nm) profile of cytoplasmic ribonucleoprotein complexes. (E) 18S and 28S RNA profile determined by quantitative RT-PCR. (F) Quantification of the Renilla luciferase reporter mRNA fractionated across a 10&#8211;50% sucrose gradient by quantitative RT-PCR.</p>
###xml 1460 3011 1456 3003 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">EB2 cosediments with polyribosomes and enhances utilization of its target mRNA by the translation machinery. (<bold>A</bold>, <bold>B</bold> and <bold>C</bold>) Cell cytosolic extracts of HEK293T transfected with pcDNAGlobinRen alone or pcDNAGlobinRen together with pCI-Flag.EB2 or pcDNAIntron-GlobinRen alone, were fractionated across 10&#8211;50% sucrose gradients. (A) Fractions from the gradient corresponding to HEK293T transfected with pcDNAGlobinRen together with pCI-Flag.EB2 were analyzed by western blotting with antibodies against the Flag epitope to detect Flag.EB2, poly(A)-binding protein (PABP) or &#945;-tubulin. (Top) UV absorbance (254 nm) profile of cytoplasmic ribonucleoprotein complexes. (B) 18S and 28S RNA profile determined by quantitative RT-PCR. (C) Quantification of the Renilla luciferase reporter mRNA fractionated across 10&#8211;50% sucrose gradients by quantitative RT-PCR. (Top panel) HEK293T transfected with pcDNAGlobinRen. (Middle panel) HEK293T transfected with pcDNAGlobinRen together with pCI-Flag.EB2. (Bottom panel) HEK293T transfected with pcDNAIntron-GlobinRen. (<bold>D</bold>, <bold>E</bold> and <bold>F</bold>) An EDTA-treated cytoplasmic extract of HEK 293T cells transfected with pcDNAGlobinRen together with pCIF.EB2 was fractionated across a 10&#8211;50% sucrose gradients. (D) EB2 is relocalized to the top of the gradient. (Top) UV absorbance (254 nm) profile of cytoplasmic ribonucleoprotein complexes. (E) 18S and 28S RNA profile determined by quantitative RT-PCR. (F) Quantification of the Renilla luciferase reporter mRNA fractionated across a 10&#8211;50% sucrose gradient by quantitative RT-PCR.</p></caption>
###xml 3011 3011 3003 3003 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp497f5"/>
###xml 1451 3011 1447 3003 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="48">EB2 cosediments with polyribosomes and enhances utilization of its target mRNA by the translation machinery. (<bold>A</bold>, <bold>B</bold> and <bold>C</bold>) Cell cytosolic extracts of HEK293T transfected with pcDNAGlobinRen alone or pcDNAGlobinRen together with pCI-Flag.EB2 or pcDNAIntron-GlobinRen alone, were fractionated across 10&#8211;50% sucrose gradients. (A) Fractions from the gradient corresponding to HEK293T transfected with pcDNAGlobinRen together with pCI-Flag.EB2 were analyzed by western blotting with antibodies against the Flag epitope to detect Flag.EB2, poly(A)-binding protein (PABP) or &#945;-tubulin. (Top) UV absorbance (254 nm) profile of cytoplasmic ribonucleoprotein complexes. (B) 18S and 28S RNA profile determined by quantitative RT-PCR. (C) Quantification of the Renilla luciferase reporter mRNA fractionated across 10&#8211;50% sucrose gradients by quantitative RT-PCR. (Top panel) HEK293T transfected with pcDNAGlobinRen. (Middle panel) HEK293T transfected with pcDNAGlobinRen together with pCI-Flag.EB2. (Bottom panel) HEK293T transfected with pcDNAIntron-GlobinRen. (<bold>D</bold>, <bold>E</bold> and <bold>F</bold>) An EDTA-treated cytoplasmic extract of HEK 293T cells transfected with pcDNAGlobinRen together with pCIF.EB2 was fractionated across a 10&#8211;50% sucrose gradients. (D) EB2 is relocalized to the top of the gradient. (Top) UV absorbance (254 nm) profile of cytoplasmic ribonucleoprotein complexes. (E) 18S and 28S RNA profile determined by quantitative RT-PCR. (F) Quantification of the Renilla luciferase reporter mRNA fractionated across a 10&#8211;50% sucrose gradient by quantitative RT-PCR.</p></caption><graphic xlink:href="gkp497f5"/></fig>
To determine whether EB2 is associated with the translation machinery and to find out whether it increases the association of its target mRNAs with polyribosomes, we performed sucrose gradient analysis to separate polyribosomes from monoribosomes and uncomplexed ribosomal subunits. HEK293T cells were transfected with pcDNAIntron-GlobinRen alone, pcDNAGlobinRen alone or pcDNAGlobinRen together with pCI-Flag.EB2. Cell extracts were prepared and fractionated on 10-50% sucrose gradients and fractions were first analyzed by western blotting. An example of the UV absorbance profile of the gradients is shown in Figure 5A and the corresponding 18S and 28S RNA profile, determined by RT-PCR, in Figure 5B. UV absorbance and the 18S/28S RNA profiles from all gradients were very similar. The polyribosome distribution of EB2 was compared with that of PABP, a general translation factor for polyA+ mRNA (45,46) (Figure 5A). As expected, PABP was present across the gradient from mRNPs to polyribosomal fractions. Interestingly, EB2 cosedimented with the 80S ribosome but was also found in the lighter polysomal fractions. As a control, alpha-tubulin was only found associated with the uncomplexed ribosomal subunit fractions. Furthermore, treatment of cytoplasmic extracts with EDTA, which is known to induce a dissociation of mono- and polyribosomes into ribosomal subunits, induced a redistribution of EB2 to the top of the gradient (Figure 5D and E). Figure 5.EB2 cosediments with polyribosomes and enhances utilization of its target mRNA by the translation machinery. (A, B and C) Cell cytosolic extracts of HEK293T transfected with pcDNAGlobinRen alone or pcDNAGlobinRen together with pCI-Flag.EB2 or pcDNAIntron-GlobinRen alone, were fractionated across 10-50% sucrose gradients. (A) Fractions from the gradient corresponding to HEK293T transfected with pcDNAGlobinRen together with pCI-Flag.EB2 were analyzed by western blotting with antibodies against the Flag epitope to detect Flag.EB2, poly(A)-binding protein (PABP) or alpha-tubulin. (Top) UV absorbance (254 nm) profile of cytoplasmic ribonucleoprotein complexes. (B) 18S and 28S RNA profile determined by quantitative RT-PCR. (C) Quantification of the Renilla luciferase reporter mRNA fractionated across 10-50% sucrose gradients by quantitative RT-PCR. (Top panel) HEK293T transfected with pcDNAGlobinRen. (Middle panel) HEK293T transfected with pcDNAGlobinRen together with pCI-Flag.EB2. (Bottom panel) HEK293T transfected with pcDNAIntron-GlobinRen. (D, E and F) An EDTA-treated cytoplasmic extract of HEK 293T cells transfected with pcDNAGlobinRen together with pCIF.EB2 was fractionated across a 10-50% sucrose gradients. (D) EB2 is relocalized to the top of the gradient. (Top) UV absorbance (254 nm) profile of cytoplasmic ribonucleoprotein complexes. (E) 18S and 28S RNA profile determined by quantitative RT-PCR. (F) Quantification of the Renilla luciferase reporter mRNA fractionated across a 10-50% sucrose gradient by quantitative RT-PCR.
###end p 47
###begin p 48
###xml 110 111 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 113 114 113 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 119 120 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1055 1056 1051 1052 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1058 1059 1054 1055 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1064 1065 1060 1061 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
EB2 cosediments with polyribosomes and enhances utilization of its target mRNA by the translation machinery. (A, B and C) Cell cytosolic extracts of HEK293T transfected with pcDNAGlobinRen alone or pcDNAGlobinRen together with pCI-Flag.EB2 or pcDNAIntron-GlobinRen alone, were fractionated across 10-50% sucrose gradients. (A) Fractions from the gradient corresponding to HEK293T transfected with pcDNAGlobinRen together with pCI-Flag.EB2 were analyzed by western blotting with antibodies against the Flag epitope to detect Flag.EB2, poly(A)-binding protein (PABP) or alpha-tubulin. (Top) UV absorbance (254 nm) profile of cytoplasmic ribonucleoprotein complexes. (B) 18S and 28S RNA profile determined by quantitative RT-PCR. (C) Quantification of the Renilla luciferase reporter mRNA fractionated across 10-50% sucrose gradients by quantitative RT-PCR. (Top panel) HEK293T transfected with pcDNAGlobinRen. (Middle panel) HEK293T transfected with pcDNAGlobinRen together with pCI-Flag.EB2. (Bottom panel) HEK293T transfected with pcDNAIntron-GlobinRen. (D, E and F) An EDTA-treated cytoplasmic extract of HEK 293T cells transfected with pcDNAGlobinRen together with pCIF.EB2 was fractionated across a 10-50% sucrose gradients. (D) EB2 is relocalized to the top of the gradient. (Top) UV absorbance (254 nm) profile of cytoplasmic ribonucleoprotein complexes. (E) 18S and 28S RNA profile determined by quantitative RT-PCR. (F) Quantification of the Renilla luciferase reporter mRNA fractionated across a 10-50% sucrose gradient by quantitative RT-PCR.
###end p 48
###begin p 49
###xml 113 121 113 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 345 351 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">middle</italic>
###xml 356 366 356 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panels</italic>
###xml 590 602 590 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom panel</italic>
###xml 715 723 715 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
We then analyzed the distribution of the reporter mRNAs throughout our sucrose gradients by quantitative RT-PCR (Figure 5C). Interestingly, the proportion of the Renilla luciferase mRNA generated from the intron-less construct, which is found associated with the polyribosomal fractions, is greatly increased in the presence of EB2 (compare the middle and top panels). Furthermore, in the latter case, the profile of repartition of the Renilla luciferase mRNA throughout the gradient is very similar to that obtained with the luciferase mRNA generated from the intron-containing construct (bottom panel). As expected, Renilla luciferase mRNA moved to the lighter fractions of the gradient following EDTA treatment (Figure 5F). Taken together, these data suggest that EB2 directly increases the utilization of its target reporter mRNA by the translation machinery.
###end p 49
###begin title 50
EB2 viral homolog proteins exhibit different effects on mRNA generated from intronless genes
###end title 50
###begin p 51
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 681 683 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 684 686 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 971 979 960 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1199 1207 1188 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1592 1600 1581 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1902 1910 1891 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1914 1923 1903 1912 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 2024 2025 2013 2014 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2226 2227 2215 2216 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1923 2507 1912 2496 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="52">Differential effects on translation from EB2-related proteins derived from different herpesviruses. (<bold>A</bold>) Cytoplasmic luciferase mRNA levels monitored by quantitative PCR in HeLa cells mock transfected (pCI) or transfected with 500 ng of EBV EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding plasmids. (<bold>B</bold>) Translation rate. Luciferase activity was normalized by the amount of cytoplasmic mRNAs from cells mock transfected (pCI) or transfected with EBV EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding vectors, together with the reporter plasmid pcDNAGlobinRen. AU: arbitrary units.</p>
###xml 1923 2507 1912 2496 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="52">Differential effects on translation from EB2-related proteins derived from different herpesviruses. (<bold>A</bold>) Cytoplasmic luciferase mRNA levels monitored by quantitative PCR in HeLa cells mock transfected (pCI) or transfected with 500 ng of EBV EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding plasmids. (<bold>B</bold>) Translation rate. Luciferase activity was normalized by the amount of cytoplasmic mRNAs from cells mock transfected (pCI) or transfected with EBV EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding vectors, together with the reporter plasmid pcDNAGlobinRen. AU: arbitrary units.</p></caption>
###xml 2507 2507 2496 2496 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp497f6"/>
###xml 1914 2507 1903 2496 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="52">Differential effects on translation from EB2-related proteins derived from different herpesviruses. (<bold>A</bold>) Cytoplasmic luciferase mRNA levels monitored by quantitative PCR in HeLa cells mock transfected (pCI) or transfected with 500 ng of EBV EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding plasmids. (<bold>B</bold>) Translation rate. Luciferase activity was normalized by the amount of cytoplasmic mRNAs from cells mock transfected (pCI) or transfected with EBV EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding vectors, together with the reporter plasmid pcDNAGlobinRen. AU: arbitrary units.</p></caption><graphic xlink:href="gkp497f6"/></fig>
###xml 374 378 <span type="species:ncbi:10298?0.9473684210526315">HSV1</span>
###xml 380 402 <span type="species:ncbi:10298">herpes simplex virus 1</span>
###xml 491 494 <span type="species:ncbi:10376">EBV</span>
###xml 529 532 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 2159 2162 <span type="species:ncbi:10376">EBV</span>
###xml 2168 2173 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 2371 2374 <span type="species:ncbi:10376">EBV</span>
###xml 2380 2385 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Herpesviruses code for EB2 homolog proteins that also serve as viral mRNA export factors. Interestingly, despite their similarities, EB2 homolog proteins cannot trans-complement each other for viral production (35,47). Thus, it was of interest to test the effect of EB2-related proteins in our system. For this, we used proteins from each herpesvirus sub-family: ICP27 from HSV1 (herpes simplex virus 1), an alpha-herpesvirus, ORF57 from KSHV (Kaposi's sarcoma-associated herpesvirus), like EBV a gamma-herpesvirus and UL69 from CMV (cytomegalovirus), a beta-herpesvirus. Among these proteins, only ICP27 has been previously shown to stimulate translation of specific viral mRNAs (48,49). In order to monitor the effect of these proteins in our luciferase reporter system, we cotransfected HeLa cells with the intronless luciferase construct and expression plasmids for the different EB2-related herpesvirus proteins and we quantified both cytoplasmic mRNA accumulation (Figure 6A) and luciferase activity (not shown). Luciferase expression was again normalized to the amount of cytoplasmic luciferase-encoding mRNAs in order to specifically measure the impact of each viral protein on translation (Figure 6B). Expression of each of the viral proteins was verified by western blotting (data not shown). Unexpectedly, the effect observed with EB2 was not conserved for all of the homolog proteins. Indeed, only UL69 led to a strong luciferase translation stimulation similar to that of EB2 (i.e. 4-5-fold stimulation of translation), whereas ICP27 and ORF57 did not have a significant effect (Figure 6B). This was probably due to the fact that neither ICP27 nor ORF57 appear to export the luciferase mRNA (expression of ICP27 led in fact to a 40% reduction of the amount of luciferase cytoplasmic mRNA) contrary to EB2 and UL69, which provoked a 4-5-fold increase of luciferase cytoplasmic mRNA levels (Figure 6A). Figure 6.Differential effects on translation from EB2-related proteins derived from different herpesviruses. (A) Cytoplasmic luciferase mRNA levels monitored by quantitative PCR in HeLa cells mock transfected (pCI) or transfected with 500 ng of EBV EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding plasmids. (B) Translation rate. Luciferase activity was normalized by the amount of cytoplasmic mRNAs from cells mock transfected (pCI) or transfected with EBV EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding vectors, together with the reporter plasmid pcDNAGlobinRen. AU: arbitrary units.
###end p 51
###begin p 52
###xml 101 102 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 303 304 303 304 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 236 239 <span type="species:ncbi:10376">EBV</span>
###xml 245 250 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 448 451 <span type="species:ncbi:10376">EBV</span>
###xml 457 462 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
Differential effects on translation from EB2-related proteins derived from different herpesviruses. (A) Cytoplasmic luciferase mRNA levels monitored by quantitative PCR in HeLa cells mock transfected (pCI) or transfected with 500 ng of EBV EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding plasmids. (B) Translation rate. Luciferase activity was normalized by the amount of cytoplasmic mRNAs from cells mock transfected (pCI) or transfected with EBV EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding vectors, together with the reporter plasmid pcDNAGlobinRen. AU: arbitrary units.
###end p 52
###begin p 53
This result shows that EB2 homologs derived from related viruses have differential effects on a heterologous mRNA and suggests that export of the mRNA and stimulation of its translation are strongly linked.
###end p 53
###begin title 54
DISCUSSION
###end title 54
###begin p 55
###xml 1295 1298 1295 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 376 379 <span type="species:ncbi:10376">EBV</span>
###xml 884 887 <span type="species:ncbi:10376">EBV</span>
###xml 1163 1166 <span type="species:ncbi:10376">EBV</span>
###xml 1283 1286 <span type="species:ncbi:10376">EBV</span>
Although the role of EB2 in the nuclear export of unspliced RNAs has been extensively studied, its effect on translation has never been evaluated. With the growing evidence that cellular mRNA splicing and export factors are also able to modulate translation of spliced mRNAs, we decided to test whether the viral protein EB2 could also affect translation. Indeed, most of the EBV early and late genes do not contain any intron, suggesting that both export and translation of the corresponding mRNAs should be very inefficient. However, this defect is overcome by expression of the early viral protein EB2, which interacts with the viral mRNAs to facilitate their cytoplasmic accumulation. This tight interaction of EB2 with the exported mRNA and its transit to the cytoplasm strongly suggested that EB2 could also affect translation. In fact, expression of EB2 in cells coding for an EBV-derived unspliced RNA (BDLF1) led to a strong stimulation of BDLF1 accumulation that did not depend on an increase in cytoplasmic levels of the corresponding mRNA. This result indicates that, besides its role as a nuclear export factor, EB2 can also stimulate translation of EBV unspliced RNAs. Interestingly, the effect of EB2 on protein accumulation from unspliced mRNAs did not depend on any EBV-derived cis-acting sequence since expression of an artificial unspliced mRNA encoding for the Renilla luciferase was also strongly stimulated without affecting protein stability. Surprisingly, even though EB2 lacked a requirement for a specific RNA sequence, its expression did not affect global cellular mRNA translation suggesting a role for EB2 on translation of only a specific subset of mRNAs.
###end p 55
###begin p 56
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 108 111 <span type="species:ncbi:10376">EBV</span>
Since EB2 has been shown to export mostly mRNAs generated from intronless genes (23) including its specific EBV-encoded target genes we tested the effect of the introduction of intronic sequences within the 5'UTR of our reporter gene. Interestingly, we found that after addition of an intron within the luciferase reporter construct, EB2 was no longer able to stimulate translation, whereas it had a strong effect on the same RNA transcribed from an intronless construct.
###end p 56
###begin p 57
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
These results together with previous results showing that EB2 can interact with mRNA independently of any specific sequence (50) suggest that EB2 can bind to both spliced and unspliced mRNAs. However, in the case of unspliced mRNAs, which do not recruit the normal set of splicing factors, EB2 would allow their export and stimulate their translation to levels similar to those of spliced mRNAs. In the case of intron-containing genes, EB2 could also bind to the mRNA but we suggest that either it is excluded from the mRNA by a cellular splicing or export factor, or it is exported to the cytoplasm with the spliced mRNA. In the latter case, its effect on translation would be redundant in the presence of splicing proteins. Indeed, it is possible that EB2 recruited cotranscriptionally to nascent mRNAs is able to interact with an as yet unknown cellular factor necessary for translation stimulation of spliced mRNAs. This would explain the stimulation of the translation of intronless mRNAs in the presence of EB2. On the contrary, if EB2 also interacts with spliced mRNAs, it could interfere with the cellular factors that normally stimulate their export and translation. This would explain the mild inhibition of export and translation that we observed upon addition of an intron in our luciferase reporter construct.
###end p 57
###begin p 58
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1175 1177 1175 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1292 1299 1292 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1301 1303 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1459 1466 1459 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 493 496 <span type="species:ncbi:10376">EBV</span>
In accordance with the fact that EB2 specifically stimulates export and translation of mRNAs generated from intronless genes we have shown that cellular mRNAs, which are, in the majority, generated from intron-containing genes, are not globally affected by expression of EB2. There are however few cellular genes which are known for their absence of introns. It would be interesting to look at the effect of EB2 on the export and translation of mRNAs generated from such genes. In the case of EBV, most of the viral mRNAs of the productive cycle are intronless. We have previously shown that EB2 is necessary for the efficient export of the majority of these, but it is interesting to note that some are efficiently exported even in the absence of EB2, suggesting that they use an alternative export pathway, independent of splicing. Such an alternative pathway has been previously reported with the SR proteins, 9G8 and ASF/SF2, which have been found to promote the recruitment of TAP to mRNPs (51). Another interesting example of mRNA generated from an intronless gene and which is not affected by EB2 is the firefly luciferase mRNA expressed from an intronless construct (25). However, although there is no effect of EB2 on firefly luciferase expression, EB2 bound efficiently to its mRNA in vivo (25). Again, it is likely that this mRNA uses an alternative pathway for its export, independent of splicing. Thus, even if EB2 is associated with these mRNAs in vivo, its effect is probably redundant as discussed above in the case of spliced mRNAs.
###end p 58
###begin p 59
###xml 602 605 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 1034 1035 1034 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1332 1333 1332 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
In order to definitively conclude on a direct effect of EB2 on translation efficiency we studied the association of Renilla luciferase mRNAs with polyribosomes. The data clearly showed that the proportion of Renilla luciferase mRNAs associated with polyribosomes is largely increased in the presence of EB2. Moreover, we found that there is also an association of EB2 with polyribosomes, suggesting that EB2 binds the mRNPs in the nucleus, where it stimulates their export and then remains associated with the mRNPs as far as the polyribosomes. Taken together, these results argue for a role of EB2 in cis similar to that of the EJC proteins responsible for the translation stimulation of cellular mRNAs. One proposed mechanism involves an interaction between the EJC and the 48S preinitiation complex mediated by an interaction between Y14:Magoh and the protein PYM (52). Another mechanism involves the EJC-dependent recruitment of the 40S ribosomal protein S6 kinase 1 (S6K1) which is a central player in the TOR signaling cascade (7). When activated by the TOR pathway, S6K1 enhances translation initiation both by activating stimulatory factors and by inactivating inhibitory factors bound at the 5' cap of mRNAs. The SR protein ASF/SF2 has also recently been reported to enhance translation initiation via recruitment of mTOR (8).
###end p 59
###begin p 60
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 1291 1293 1291 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1294 1296 1294 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1297 1299 1297 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 1611 1613 1611 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 196 217 <span type="species:ncbi:10359">human cytomegalovirus</span>
###xml 489 516 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Finally, we tested several EB2 homologous proteins from other herpesviruses for their ability to stimulate translation of the intronless luciferase gene. Among the proteins tested, only UL69 from human cytomegalovirus (hCMV) behaves like EB2, while ICP27 and ORF57 were unable to stimulate luciferase translation. For UL69, this is the first report suggesting that this protein plays a role in stimulation of translation. On the contrary, it has been previously shown that ICP27 (from the herpes simplex virus type 1) plays a role in regulating translation of a subset of late viral mRNAs (48,49,53). However, the interaction between ICP27 and the viral mRNAs has been shown to depend on specific RNA sequences distributed along the viral genome (54). In addition, ICP27 has been shown to be able to stimulate translation of a luciferase mRNA only if it was previously tethered to it (53). Thus, it is not surprising that in our system, ICP27 does not stimulate Renilla luciferase mRNA translation nor cytoplasmic Renilla luciferase mRNA accumulation, suggesting that translation stimulation is probably dependent on the binding of the herpes simplex virus proteins to the mRNA. Since all the herpesvirus EB2 homologous proteins have been shown to shuttle from the nucleus to the cytoplasm (31,38,55) it is tempting to speculate that they first interact with their unspliced mRNA targets inside the nucleus, and then shuttle to the cytoplasm bound to these mRNAs where they play a role in translation. Accordingly, it is interesting to notice that ICP27 has also been shown to be associated with polyribosomes (53). Taken together, these results suggest firstly that both EB2 and the herpesvirus EB2 homologous proteins have a direct role on translation of the mRNA they interact with, and secondly that protein-mRNA interaction, mRNA export and translation stimulation are strongly linked.
###end p 60
###begin p 61
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 626 629 <span type="species:ncbi:10376">EBV</span>
EB2 expression is essential for viral particle production and its absence leads to very poor viral DNA replication probably because of the low expression of early viral mRNAs that depend on EB2 for their export (i.e. BALF5 and BALF2) (27). An even more drastic effect was seen on most of the late viral mRNAs (28,56). We have shown here that EB2 expression leads to a 25-fold stimulation of renilla luciferase reporter gene expression with a cytoplasmic accumulation of the corresponding mRNA stimulated 3.5-fold and the translation itself stimulated from 5- to 7-fold. This suggests that the essential role of EB2 during the EBV productive cycle could be explained by a combined role on mRNA export and translation stimulation.
###end p 61
###begin title 62
SUPPLEMENTARY DATA
###end title 62
###begin p 63
 are available at NAR Online.
###end p 63
###begin title 64
[Supplementary Data]
###end title 64
###begin title 65
FUNDING
###end title 65
###begin p 66
'Institut National de la Sante et de la Recherche Medicale' (INSERM), the 'Agence Nationale pour la Recherche' (ANR) [ANR MIME: grant number RPV06120CSA (to E.M.) and ANR blanche: grant number 06-0290-01 (to T.O.)] and the pole of competitivity Lyon Biopole. Fellowship from the 'Association pour la Recherche contre le cancer' (ARC) (to C.M.-P.); fellowship from the 'Ministere de la Recherche et de la Technologie' (MRT to E.R.). E.M. is a CNRS scientist. Funding for open access charge: INSERM.
###end p 66
###begin p 67
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 67
###begin title 68
ACKNOWLEDGEMENTS
###end title 68
###begin p 69
###xml 279 284 <span type="species:ncbi:9606">human</span>
We thank B. Blanquier from the 'Plateau d'analyse genetique' of IFR128 for advice on quantitative PCR. We thank A. Chaboud and Y. Tauran from the 'Plateau de production et d'analyse des proteines' of IFR 128 for use of the AKTA purifier. We thank Dr S. Morley for providing anti-human PABP antibodies and Dr D. Levy and S. Delpeut for providing PKR-deficient cells. We also thank the Reseau Herpesvirus and Cancer for its support. Finally, we thank Dr R. Buckland for reading the manuscript.
###end p 69
###begin title 70
REFERENCES
###end title 70
###begin article-title 71
Pre-mRNA processing reaches back to transcription and ahead to translation
###end article-title 71
###begin article-title 72
eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation
###end article-title 72
###begin article-title 73
Conducting the initiation of protein synthesis: the role of eIF4G
###end article-title 73
###begin article-title 74
Molecular mechanisms of translation initiation in eukaryotes
###end article-title 74
###begin article-title 75
How introns influence and enhance eukaryotic gene expression
###end article-title 75
###begin article-title 76
Analysis of the stimulatory effect of splicing on mRNA production and utilization in mammalian cells
###end article-title 76
###begin article-title 77
SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs
###end article-title 77
###begin article-title 78
The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1
###end article-title 78
###begin article-title 79
A quantitative analysis of intron effects on mammalian gene expression
###end article-title 79
###begin article-title 80
NFAR-1 and -2 modulate translation and are required for efficient host defense
###end article-title 80
###begin article-title 81
A novel role for shuttling SR proteins in mRNA translation
###end article-title 81
###begin article-title 82
Exon junction complexes mediate the enhancing effect of splicing on mRNA expression
###end article-title 82
###begin article-title 83
Multiple roles of the SR protein family in splicing regulation
###end article-title 83
###begin article-title 84
Determinants of SR protein specificity
###end article-title 84
###begin article-title 85
The shuttling SR protein 9G8 plays a role in translation of unspliced mRNA containing a constitutive transport element
###end article-title 85
###begin article-title 86
Overexpression of TAP/p15 heterodimers bypasses nuclear retention and stimulates nuclear mRNA export
###end article-title 86
###begin article-title 87
Tap and NXT promote translation of unspliced mRNA
###end article-title 87
###begin article-title 88
RNA export mediated by tap involves NXT1-dependent interactions with the nuclear pore complex
###end article-title 88
###begin article-title 89
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 29 64 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region
###end article-title 89
###begin article-title 90
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA
###end article-title 90
###begin article-title 91
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Regulation of HIV-1 env mRNA translation by Rev protein
###end article-title 91
###begin article-title 92
Translational control of retroviruses
###end article-title 92
###begin article-title 93
###xml 54 72 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The C-terminal region but not the Arg-X-Pro repeat of Epstein-Barr virus protein EB2 is required for its effect on RNA splicing and transport
###end article-title 93
###begin article-title 94
###xml 91 109 <span type="species:ncbi:10376">Epstein-Barr virus</span>
A novel nuclear export signal and a REF interaction domain both promote mRNA export by the Epstein-Barr virus EB2 protein
###end article-title 94
###begin article-title 95
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus SM protein interacts with mRNA in vivo and mediates a gene-specific increase in cytoplasmic mRNA
###end article-title 95
###begin article-title 96
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus EB2 protein exports unspliced RNA via a Crm-1-independent pathway
###end article-title 96
###begin article-title 97
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus
###end article-title 97
###begin article-title 98
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus mRNA export factor EB2 is essential for intranuclear capsid assembly and production of gp350
###end article-title 98
###begin article-title 99
###xml 61 88 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
ICP27 interacts with the RNA export factor Aly/REF to direct herpes simplex virus type 1 intronless mRNAs to the TAP export pathway
###end article-title 99
###begin article-title 100
Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway
###end article-title 100
###begin article-title 101
ICP27 mediates HSV RNA export by shuttling through a leucine-rich nuclear export signal and binding viral intronless RNAs through an RGG motif
###end article-title 101
###begin article-title 102
###xml 35 56 <span type="species:ncbi:10359">human cytomegalovirus</span>
The UL69 transactivator protein of human cytomegalovirus interacts with DEXD/H-Box RNA helicase UAP56 to promote cytoplasmic accumulation of unspliced RNA
###end article-title 102
###begin article-title 103
The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an mRNA export factor
###end article-title 103
###begin article-title 104
The prototype gamma 2 herpesvirus nucleocytoplasmic shuttling protein, ORF57, transports viral RNA through the cellular mRNA export pathway
###end article-title 104
###begin article-title 105
Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production
###end article-title 105
###begin article-title 106
###xml 155 169 <span type="species:ncbi:10245">Vaccinia virus</span>
IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein
###end article-title 106
###begin article-title 107
###xml 30 36 <span type="species:ncbi:9986">rabbit</span>
Back to basics: the untreated rabbit reticulocyte lysate as a competitive system to recapitulate cap/poly(A) synergy and the selective advantage of IRES-driven translation
###end article-title 107
###begin article-title 108
###xml 104 125 <span type="species:ncbi:10359">human cytomegalovirus</span>
A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shuttling of the human cytomegalovirus transactivator protein pUL69
###end article-title 108
###begin article-title 109
###xml 101 108 <span type="species:ncbi:8355">Xenopus</span>
The association of initiation factor 4F with poly(A)-binding protein is enhanced in serum-stimulated Xenopus kidney cells
###end article-title 109
###begin article-title 110
An intron with a constitutive transport element is retained in a Tap messenger RNA
###end article-title 110
###begin article-title 111
Northern blot analysis of mRNA from mammalian polyribosomes
###end article-title 111
###begin article-title 112
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 77 83 <span type="species:ncbi:10090">murine</span>
###xml 175 201 <span type="species:ncbi:12104">encephalomyocarditis virus</span>
Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth
###end article-title 112
###begin article-title 113
Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase
###end article-title 113
###begin article-title 114
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression
###end article-title 114
###begin article-title 115
The roles of cytoplasmic poly(A)-binding proteins in regulating gene expression: a developmental perspective
###end article-title 115
###begin article-title 116
Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression
###end article-title 116
###begin article-title 117
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 24 27 <span type="species:ncbi:10376">EBV</span>
The Epstein-Barr virus (EBV) protein EB2 is an mRNA export factor essential for virus production
###end article-title 117
###begin article-title 118
###xml 35 62 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Control of VP16 translation by the herpes simplex virus type 1 immediate-early protein ICP27
###end article-title 118
###begin article-title 119
Herpes simplex virus ICP27 increases translation of a subset of viral late mRNAs
###end article-title 119
###begin article-title 120
###xml 16 34 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 36 39 <span type="species:ncbi:10376">EBV</span>
A region of the Epstein-Barr virus (EBV) mRNA export factor EB2 containing an arginine-rich motif mediates direct binding to RNA
###end article-title 120
###begin article-title 121
SR splicing factors serve as adapter proteins for TAP-dependent mRNA export
###end article-title 121
###begin article-title 122
PYM binds the cytoplasmic exon-junction complex and ribosomes to enhance translation of spliced mRNAs
###end article-title 122
###begin article-title 123
Direct stimulation of translation by the multifunctional herpesvirus ICP27 protein
###end article-title 123
###begin article-title 124
Identification of herpes simplex virus RNAs that interact specifically with regulatory protein ICP27 in vivo
###end article-title 124
###begin article-title 125
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human ORF57 gene and its properties
###end article-title 125
###begin article-title 126
###xml 18 36 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Multiple roles of Epstein-Barr virus SM protein in lytic replication
###end article-title 126

